Martin B. Leon

Martin B. Leon's AcademicInfluence.com Rankings

Martin B. Leon

Medical

#478

World Rank

#654

Historical Rank

Cardiology

#15

World Rank

#15

Historical Rank

medical Degrees

Martin B. Leon

Philosophy

#2112

World Rank

#3679

Historical Rank

Logic

#445

World Rank

#842

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Martin B. Leon's Degrees

Doctorate Medicine University of Buenos Aires

Why Is Martin B. Leon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Martin B. Leon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. (2010) (6019)
Transcatheter versus surgical aortic-valve replacement in high-risk patients. (2011) (5212)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. (2003) (4449)
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. (1994) (4375)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. (2016) (3614)
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description (2002) (2953)
Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients (2019) (2461)
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. (2004) (2200)
Extrapulmonary manifestations of COVID-19 (2020) (1998)
A controlled trial of renal denervation for resistant hypertension. (2014) (1851)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
Two-year outcomes after transcatheter or surgical aortic-valve replacement. (2012) (1727)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. (2007) (1694)
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting (1998) (1635)
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis (2007) (1494)
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. (2012) (1491)
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. (1996) (1313)
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (1308)
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. (1999) (1242)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. (2012) (1186)
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. (2012) (997)
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium† (2010) (975)
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. (1996) (931)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis (2012) (918)
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis (2016) (877)
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. (2011) (842)
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. (2004) (833)
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. (1990) (823)
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. (1998) (823)
Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions (2004) (803)
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. (1994) (789)
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. (1997) (755)
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. (2014) (755)
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model (2001) (743)
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. (2005) (741)
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. (2000) (734)
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (715)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2015) (711)
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. (1993) (702)
Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts (2002) (683)
Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. (2004) (678)
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. (1999) (676)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
Coronary artery imaging with intravascular high-frequency ultrasound. (1990) (640)
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. (2001) (639)
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study (2017) (636)
Impaired Left Ventricular Diastolic Filling in Patients with Coronary Artery Disease: Assessment with Radionuclide Angiography (1981) (630)
Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study (1991) (625)
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. (1995) (607)
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement (2013) (597)
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. (2013) (594)
Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies (2009) (582)
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. (2000) (581)
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. (1995) (562)
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. (2005) (558)
Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis (2004) (553)
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. (1995) (527)
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. (2012) (527)
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. (2001) (525)
Global experience in cervical carotid artery stent placement (2000) (510)
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. (1998) (485)
Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. (1997) (481)
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. (2013) (477)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. (2015) (477)
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. (2004) (477)
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. (2009) (472)
Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. (2003) (470)
Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. (2012) (468)
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. (1985) (463)
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. (1997) (454)
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. (2012) (450)
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. (1988) (448)
Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (447)
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. (2005) (440)
The Variety of Cardiovascular Presentations of COVID-19 (2020) (437)
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. (2004) (434)
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy (2004) (431)
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. (2015) (423)
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. (2002) (416)
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. (2012) (412)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II (2005) (411)
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). (1987) (410)
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (2017) (407)
Effects of Verapamil on Left Ventricular Systolic Function and Diastolic Filling in Patients with Hypertrophic Cardiomyopathy (1981) (404)
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. (2013) (392)
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. (1996) (389)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. (2000) (373)
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. (2015) (366)
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. (2006) (366)
Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. (2004) (365)
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. (2020) (356)
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. (1995) (351)
Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery (2004) (346)
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. (2017) (345)
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. (2015) (345)
Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis (2013) (338)
Seeding of intravascular stents with genetically engineered endothelial cells. (1989) (336)
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. (1997) (327)
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. (2010) (318)
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. (2012) (317)
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. (2017) (315)
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. (2000) (311)
Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis (2000) (310)
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis (2008) (310)
Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. (2014) (306)
Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial (2012) (306)
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2016) (301)
Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis (2011) (295)
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention (2019) (293)
Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. (1998) (289)
Long-term outcome of percutaneous coronary intervention for chronic total occlusions. (2011) (286)
Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis (2004) (282)
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. (2016) (281)
Current global status of carotid artery stent placement. (1998) (278)
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). (2012) (276)
Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients. (2000) (275)
Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) (2012) (271)
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. (1985) (270)
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. (2018) (267)
Restenosis After Placement of Palmaz‐Schatz Stents in Native Coronary Arteries: Initial Results of a Multicenter Experience (1992) (266)
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk (2019) (266)
Vascular Complications After Balloon and New Device Angioplasty (1993) (266)
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial (2004) (265)
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. (2017) (257)
Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis (2015) (256)
Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. (1997) (252)
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. (2018) (252)
Staging classification of aortic stenosis based on the extent of cardiac damage (2017) (246)
Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. (1999) (245)
Effect of the Distal-Balloon Protection System on Microembolization During Carotid Stenting (2001) (243)
Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes (2003) (242)
Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. (1997) (242)
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. (2010) (242)
Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. (1999) (240)
Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. (2000) (239)
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. (2021) (236)
Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. (1995) (235)
Acute renal failure requiring dialysis after percutaneous coronary interventions (2001) (235)
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. (2001) (233)
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. (2005) (232)
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). (2012) (231)
Emergent Use of Balloon‐Expandable Coronary Artery Stenting for Failed Percutaneous Transluminal Coronary Angioplasty (1992) (230)
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. (2006) (230)
Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial (2004) (228)
Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. (2005) (228)
Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. (2017) (225)
Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. (2010) (225)
Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. (1997) (222)
Clinical experience with the Palmaz-Schatz coronary stent. (1991) (221)
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. (2016) (221)
Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. (1994) (219)
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). (2013) (219)
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. (2009) (213)
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. (2005) (211)
Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients (2001) (211)
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. (2019) (208)
Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. (1999) (208)
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial (2016) (208)
Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). (2015) (207)
Usefulness of a cobalt chromium coronary stent alloy. (2003) (206)
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial (2014) (205)
Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy (2015) (200)
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial (2009) (197)
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. (2008) (196)
One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. (1999) (195)
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. (1989) (195)
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. (2014) (191)
The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. (2013) (191)
Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2005) (190)
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. (2004) (189)
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. (2021) (189)
Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. (1996) (189)
Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. (1998) (188)
Early Experience With New Transcatheter Mitral Valve Replacement. (2018) (188)
Intravascular Ultrasound Evaluation of the Effect of Rotational Atherectomy in Obstructive Atherosclerotic Coronary Artery Disease (1992) (187)
Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. (2016) (187)
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. (2004) (187)
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. (2005) (186)
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. (2014) (186)
Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. (2014) (186)
Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience. The U.S. Palmaz-Schatz Stent Investigators. (1993) (184)
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. (2019) (184)
Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. (1998) (184)
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. (2002) (182)
Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. (1996) (182)
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. (2014) (182)
Relation of Clinical Presentation, Stenosis Morphology, and Operator Technique to the Procedural Results of Rotational Atherectomy and Rotational Atherectomy–Facilitated Angioplasty (1994) (182)
Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study. (2013) (181)
Aortic valve and ascending aorta guidelines for management and quality measures. (2013) (181)
Intravascular Ultrasound Classification of Plaque Distribution in Left Main Coronary Artery Bifurcations: Where Is the Plaque Really Located? (2010) (180)
Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. (1998) (180)
Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. (2011) (178)
Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. (1999) (177)
Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. (1981) (176)
Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. (1996) (176)
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. (1998) (175)
Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention (2001) (175)
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. (2005) (174)
Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. (1987) (173)
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. (2000) (173)
Limitations of angiography in the assessment of plaque distribution in coronary artery disease: a systematic study of target lesion eccentricity in 1446 lesions. (1996) (173)
Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. (2016) (172)
Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation☆ (1994) (171)
Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. (2000) (171)
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. (2006) (170)
Results of the Jostent coronary stent graft implantation in various clinical settings: Procedural and follow‐up results (2002) (170)
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? (2015) (168)
Smooth Muscle Cell Abundance and Fibroblast Growth Factors in Coronary Lesions of Patients With Nonfatal Unstable Angina A Clue to the Mechanism of Transformation From the Stable to the Unstable Clinical State (1993) (168)
Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. (1995) (167)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. (2019) (166)
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. (2008) (166)
Medical Device Development: From Prototype to Regulatory Approval (2004) (165)
Arterial responses to balloon coronary angioplasty: an intravascular ultrasound study. (1992) (165)
Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. (2000) (163)
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. (2009) (162)
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. (2015) (162)
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis (2016) (161)
Impact of preintervention intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease. (1994) (161)
Fate of lesion-related side branches after coronary artery stenting. (1993) (159)
Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. (1998) (159)
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients. (2015) (159)
Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry (2015) (159)
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). (2014) (158)
Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. (2000) (157)
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. (2019) (155)
Quantitative Assessment of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Native Coronary Arteries (2004) (155)
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. (2009) (155)
The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? (2017) (155)
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. (1981) (154)
In-stent restenosis: the Washington Hospital Center experience. (1998) (153)
Five-Year Clinical Follow-Up After Intracoronary Radiation: Results of a Randomized Clinical Trial (2002) (152)
Aortic Annular Sizing Using a Novel 3-Dimensional Echocardiographic Method: Use and Comparison With Cardiac Computed Tomography (2014) (151)
Delivery strategies to achieve therapeutic myocardial angiogenesis. (2000) (151)
Sequential intravascular ultrasound of the mechanisms of rotational atherectomy and adjunct balloon angioplasty (1993) (150)
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. (2011) (149)
Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy (2014) (149)
Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. (2012) (149)
Target lesion calcification in coronary artery disease: an intravascular ultrasound study. (1992) (148)
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). (1998) (147)
Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. (2000) (147)
Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. (2011) (147)
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. (1982) (147)
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. (1987) (146)
Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. (2010) (146)
Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. (2006) (146)
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). (2005) (143)
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention (2016) (143)
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study (2000) (143)
Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. (2016) (143)
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. (2005) (142)
Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts). (2014) (142)
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. (2000) (141)
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). (2013) (141)
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). (2014) (141)
Effect of Tricuspid Regurgitation and the Right Heart on Survival After Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valves II Inoperable Cohort (2015) (140)
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial) (2009) (138)
Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure (2002) (138)
Short- and long-term results after multivessel stenting in diabetic patients. (2004) (137)
Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. (1999) (135)
Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. (2000) (134)
Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort A) (2013) (134)
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials (2013) (134)
Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure. (2016) (133)
Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. (1996) (133)
Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A (2013) (131)
Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study. (2015) (131)
Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques (2005) (131)
Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators. (1994) (130)
Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis (2013) (130)
Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results (2005) (129)
Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) study. (2011) (127)
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. (2002) (126)
Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation (2004) (126)
Development of a Novel Prohealing Stent Designed to Deliver Sirolimus From a Biodegradable Abluminal Matrix (2010) (126)
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. (2014) (124)
Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. (2011) (124)
Safety, Efficacy, and Durability of Carotid Artery Stenting for Restenosis following Carotid Endarterectomy: A Multicenter Study (2000) (124)
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve (2017) (123)
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) (2016) (122)
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). (2005) (122)
High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. (1995) (122)
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. (2020) (122)
Human arterial surface fluorescence: atherosclerotic plaque identification and effects of laser atheroma ablation. (1988) (121)
Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. (2015) (121)
Accuracy of Fractional Flow Reserve Derived From Coronary Angiography (2019) (121)
Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. (1998) (120)
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. (2010) (119)
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. (2009) (119)
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. (2016) (117)
Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents (2005) (117)
First-in-human evaluation of a novel robotic-assisted coronary angioplasty system. (2011) (117)
Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling. (2005) (117)
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary (2011) (117)
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. (2021) (116)
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. (2008) (115)
Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis (2015) (114)
Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. (1998) (114)
Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. (2009) (113)
A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. (2015) (113)
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. (2006) (113)
Chest pain and "normal" coronary arteries--role of small coronary arteries. (1985) (112)
Gender-specific outcomes after sirolimus-eluting stent implantation. (2007) (111)
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation (2015) (111)
Coronary artery aneurysms after drug-eluting stent implantation. (2008) (111)
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. (2020) (110)
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. (2020) (110)
A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. (2009) (109)
Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. (2014) (108)
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. (2005) (107)
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. (2009) (107)
Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses (2000) (107)
Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR. (2015) (107)
Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. (2014) (106)
Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. (1994) (106)
Late stent thrombosis: Considerations and practical advice for the use of drug‐eluting stents: A report from the Society for Cardiovascular Angiography and Interventions drug‐eluting stent task force (2007) (105)
Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. (2020) (105)
3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry. (2019) (105)
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. (2011) (105)
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials (2020) (105)
Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. (2013) (104)
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. (2015) (104)
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium. (2015) (104)
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. (2015) (103)
Aortic valve and ascending aorta guidelines for management and quality measures: executive summary. (2013) (102)
Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. (1992) (101)
Medical Treatment of Aortic Stenosis (2016) (101)
Three-Year Outcomes of the DKCRUSH-V Trial Comparing DK Crush With Provisional Stenting for Left Main Bifurcation Lesions. (2019) (101)
Drug-eluting stents: costs versus clinical benefit. (2003) (100)
Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. (1999) (100)
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. (2006) (98)
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing (2014) (98)
Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications. (2019) (97)
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial (2019) (96)
Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. (2009) (96)
Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States (2020) (95)
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. (2020) (95)
Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction. (2017) (95)
Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial (2017) (94)
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). (2005) (94)
How to Define a Poor Outcome After Transcatheter Aortic Valve Replacement: Conceptual Framework and Empirical Observations From the Placement of Aortic Transcatheter Valve (PARTNER) Trial (2013) (94)
First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial. (2004) (93)
Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. (2005) (93)
A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention (2003) (93)
Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. (2016) (92)
Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natural Course and Prognostic Value (2018) (92)
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). (2014) (92)
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. (2017) (91)
Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history (2018) (90)
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. (2006) (89)
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. (2006) (89)
Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. (2014) (89)
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). (2011) (89)
Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. (2010) (88)
Mechanisms of lumen enlargement after excimer laser coronary angioplasty. An intravascular ultrasound study. (1995) (87)
Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. (2013) (85)
Impact of Aortic Annulus Size on Valve Hemodynamics and Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: Insights From the PARTNER Trial (2014) (85)
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. (2007) (85)
Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study. (1998) (85)
Coronary perforation after excimer laser coronary angioplasty: the Excimer Laser Coronary Angioplasty Registry experience. (1994) (84)
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. (2020) (84)
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program. (2013) (84)
Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents (2004) (83)
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. (2001) (83)
Comparative early and nine-month results of rotational atherectomy, stents, and the combination of both for calcified lesions in large coronary arteries. (1998) (83)
Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. (2015) (83)
A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". (2006) (83)
Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials (2007) (83)
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. (2006) (83)
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. (2017) (82)
Assessing intermediate left main coronary lesions using intravascular ultrasound. (2007) (82)
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. (2005) (82)
Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study. (2020) (82)
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. (2021) (81)
Intravascular ultrasound assessment of drug-eluting stent expansion. (2007) (81)
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). (2014) (81)
Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. (1989) (81)
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. (2020) (81)
Antithrombotic therapy in patients undergoing coronary angioplasty. (1995) (80)
Procedural results and late clinical outcomes following multivessel coronary stenting. (1998) (80)
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. (2019) (80)
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. (2021) (79)
Axial plaque redistribution as a mechanism of percutaneous transluminal coronary angioplasty. (1996) (79)
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. (2014) (79)
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
In vivo validation of intravascular ultrasound length measurements using a motorized transducer pullback system. (1996) (78)
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). (2006) (78)
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. (2020) (78)
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. (2015) (78)
Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty. (1987) (77)
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. (2009) (77)
Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque (2001) (76)
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. (2020) (76)
Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement (2016) (76)
Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis (2004) (75)
Indications for and Findings on Transthoracic Echocardiography in COVID-19 (2020) (75)
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial (2021) (75)
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. (1991) (75)
Estrogen‐eluting, phosphorylcholine‐coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model (2002) (74)
Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques. (2005) (74)
Approach to Acute Cardiovascular Complications in COVID-19 Infection. (2020) (74)
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey. (2017) (74)
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. (1993) (74)
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. (2008) (74)
Clinical and Angiographic Predictors of Short- and Long-Term Ischemic Events in Acute Coronary Syndromes: Results From the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial (2010) (74)
Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. (1997) (73)
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients. (2007) (73)
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis (2019) (73)
The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. (2013) (72)
Management strategies and future challenges for aortic valve disease (2016) (72)
A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. (2020) (72)
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions. (2006) (71)
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). (1987) (71)
Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty. (1993) (71)
Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. (1998) (71)
Effect of intracoronary stenting on intimal dissection after balloon angioplasty: results of quantitative and qualitative coronary analysis. (1991) (71)
Dual catheter technique for the treatment of severe coronary artery perforations (2010) (71)
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. (2002) (71)
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 (2021) (70)
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. (2005) (70)
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety (2016) (70)
Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry. (2016) (70)
Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. (1994) (70)
Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial (2016) (69)
Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. (2006) (69)
Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study. (1998) (69)
Fluorescence-guided laser-assisted balloon angioplasty in patients with femoropopliteal occlusions. (1990) (68)
Results of coronary angioplasty using the transluminal extraction catheter. (1992) (68)
Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. (1999) (67)
Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). (2013) (67)
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial (2017) (67)
Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus. (2013) (67)
Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography (2017) (66)
Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. (2004) (66)
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure. (2016) (66)
Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). (2014) (65)
Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. (2014) (65)
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. (2008) (65)
Gait Speed and Dependence in Activities of Daily Living in Older Adults With Severe Aortic Stenosis (2012) (65)
Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy (2015) (64)
Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. (2015) (64)
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2016) (64)
Costs of Periprocedural Complications in Patients Treated With Transcatheter Aortic Valve Replacement: Results From the Placement of Aortic Transcatheter Valve Trial (2014) (64)
Paclitaxel‐coated Gianturco–Roubin® II (GR®II) stents reduce neointimal hyperplasia in a porcine coronary in‐stent restenosis model (2001) (63)
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19 (2020) (62)
Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. (2014) (62)
Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease (2016) (62)
Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. (1998) (62)
Transplantation of Autologous Endothelial Cells Induces Angiogenesis (2003) (61)
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. (2008) (61)
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. (2013) (61)
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial. (2016) (61)
Valvular Heart Disease in Patients ≥80 Years of Age. (2018) (61)
Staging Cardiac Damage in Patients With Symptomatic Aortic Valve Stenosis. (2019) (61)
A novel technique for ultra‐low contrast administration during angiography or intervention (2010) (61)
Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery (1993) (60)
Effect of Intracoronary &ggr;-Radiation Therapy on In-Stent Restenosis: An Intravascular Ultrasound Analysis from the Gamma-1 Study (2000) (60)
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents. (2013) (60)
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. (2013) (60)
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. (2002) (60)
Excimer laser coronary angioplasty of aorto-ostial stenoses. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients. (1993) (59)
Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures. (2012) (59)
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization. (2020) (59)
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performance (2016) (59)
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). (2005) (59)
Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. (2012) (59)
Prospects for Percutaneous Valve Therapies (2007) (58)
Treatment of spontaneous coronary artery dissection with intracoronary stenting. (1996) (58)
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. (2014) (58)
Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification (2018) (58)
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. (1999) (58)
Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents. (1997) (58)
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. (2008) (57)
Intravascular ultrasound assessment of the magnitude and mechanism of coronary artery and lumen tapering. (1995) (57)
Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: observations with three dimensional intravascular ultrasound in vivo (1998) (56)
Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (56)
Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement (2017) (56)
Infective Endocarditis After Transcatheter Aortic Valve ImplantationCLINICAL PERSPECTIVE (2015) (56)
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Elu (2009) (55)
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I) (2016) (55)
Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials. (2019) (55)
Effects of intracoronary radiation on thrombosis after balloon overstretch injury in the porcine model. (1999) (55)
Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement. (2019) (55)
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. (2019) (54)
Electromechanical characterization of myocardial hibernation in a pig model. (1999) (54)
Procedural implications of intravascular ultrasound morphologic features of chronic total coronary occlusions. (2006) (54)
Radiocontrast-Induced Acute Renal Failure—Impact beyond the Acute Phase Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables. Am J Cardiol 95: 13–19, 2005 (2006) (54)
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. (2001) (54)
Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. (2000) (54)
Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement. (2019) (54)
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). (2014) (53)
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). (2015) (53)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. (2016) (53)
Rotational coronary atherectomy of ostial stenoses. (1993) (53)
Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. (2005) (53)
Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. (2001) (53)
Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions and Association With Procedural Outcomes. (2017) (53)
iCoapsys mitral valve repair system: Percutaneous implantation in an animal model (2008) (52)
Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. (2017) (52)
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting (2001) (52)
Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent. (1995) (52)
Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: A Feasibility Study. (2015) (52)
Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. (2009) (51)
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. (2009) (51)
Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents (2009) (51)
Robotic-Enhanced PCI Compared to the Traditional Manual Approach. (2014) (51)
Treatment of in-stent restenosis. (1998) (51)
Intravascular ultrasound profile analysis of ruptured coronary plaques. (2006) (51)
Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions. (2009) (51)
Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) Study (2003) (51)
Endovascular Bariatrics: First in Humans Study of Gastric Artery Embolization for Weight Loss. (2015) (51)
Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents. (2015) (51)
Sharing Data from Cardiovascular Clinical Trials--A Proposal. (2016) (50)
Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. (1997) (50)
Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention. (2014) (50)
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial. (2016) (50)
Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. (1998) (49)
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients (2020) (49)
Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). (2009) (49)
Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. (2001) (49)
Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. (2006) (48)
A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial. (1998) (48)
Impact of myocardial bridge on clinical outcome after coronary stent placement. (2009) (48)
Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. (1994) (48)
Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. (1997) (48)
Impact of target vessel on long‐term survival after percutaneous coronary intervention for chronic total occlusions (2013) (48)
Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. (2010) (47)
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation. (2020) (47)
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. (2001) (47)
Excimer Laser Coronary Angioplasty of Aorto‐Ostial Stenoses Results of the Excimer Laser Coronary Angioplasty (ELCA) Registry in the First 200 Patients (1992) (47)
Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention. (2020) (47)
Transcatheter therapeutic embolization of multiple coronary artery fistulas. (2001) (47)
Influence of patient age on acute and late clinical outcomes following Palmaz-Schatz coronary stent implantation. (2000) (47)
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis (2021) (47)
Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry (2001) (47)
Three‐dimensional intravascular ultrasonography: Reconstruction of endovascular stents in vitro and in vivo (1993) (46)
Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (< 20 mm) stents. (2000) (46)
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial (2022) (46)
Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease. (1999) (46)
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. (2017) (46)
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. (2009) (45)
Quantification Of Tissue Effects Due To A Pulsed Er:Yag Laser At 2.9 μm With Beam Delivery In A Wet Field Via Zirconium Fluoride Fibers (1987) (45)
Late thrombosis following intracoronary brachytherapy (2000) (45)
Clinical and angiographic outcome after directional coronary atherectomy. A qualitative and quantitative analysis using coronary arteriography and intravascular ultrasound. (1993) (45)
Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents. (2011) (45)
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19 (2020) (44)
Multivariate predictors of intravascular ultrasound end points after directional coronary atherectomy. (1995) (44)
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris. (1982) (44)
Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. (1995) (44)
Histopathologic analysis of in‐stent neointimal regression in a porcine coronary model (2000) (44)
Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. (2001) (44)
Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. (2020) (44)
Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2018) (43)
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy. (2018) (43)
Transcatheter versus surgical aortic valve replacement in patients with prior coronary artery bypass graft operation: a PARTNER trial subgroup analysis. (2014) (43)
Plaque Characterization of Atherosclerotic Coronary Arteries by Intravascular Ultrasound (1990) (43)
Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris. (1985) (43)
Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents. (1995) (43)
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. (2008) (43)
Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. (2019) (43)
Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts (1999) (43)
Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions. (2012) (43)
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. (2018) (43)
Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient‐level database analysis (2020) (43)
Intravascular ultrasound predictors of target lesion revascularization after stenting of protected left main coronary artery stenoses. (1999) (42)
Reproducibility of the intravascular ultrasound assessment of stent implantation in saphenous vein grafts. (1995) (42)
Intravascular stenting as a definitive treatment of spontaneous carotid artery dissection. (1997) (42)
First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS Trial Investigators. (1997) (42)
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. (2003) (42)
Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation. (2020) (42)
Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions. (2000) (41)
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting. (2009) (41)
Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts. (1999) (41)
Short- and Intermediate-Term Clinical Outcomes From Direct Myocardial Laser Revascularization Guided by Biosense Left Ventricular Electromechanical Mapping (2000) (41)
Cause of death with bare metal and sirolimus-eluting stents. (2006) (40)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (40)
Angioplasty with a Laser and Fiber Optics at 2.94 µm (1986) (40)
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. (2015) (40)
Impact of Symptomatic Peripheral Arterial Disease on 1-Year Mortality in Patients Undergoing Percutaneous Coronary Interventions (2004) (40)
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. (1996) (40)
Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). (2015) (40)
Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. (2015) (40)
Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement. (2019) (40)
Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry (2009) (40)
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. (1991) (40)
Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF (2015) (40)
One-Year Clinical Outcome After Minimally Invasive Direct Coronary Artery Bypass (2000) (39)
High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry. (1997) (39)
In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. (2008) (39)
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. (2015) (39)
Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement. (2020) (39)
Overestimation of acute lumen gain and late lumen loss by quantitative coronary angiography (compared with intravascular ultrasound) in stented lesions. (1997) (39)
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1. (2014) (39)
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry (2017) (38)
Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. (2011) (38)
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses. (2021) (38)
Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. (2019) (38)
Expanding the indications for transcatheter aortic valve implantation (2019) (38)
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy. (1993) (38)
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). (2015) (38)
The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA (2018) (38)
Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role of early percutaneous revascularization. (1999) (38)
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2015) (38)
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. (2018) (38)
Preliminary experience with adjunct directional coronary atherectomy after high-speed rotational atherectomy in the treatment of calcific coronary artery disease. (1993) (38)
Dose-dependent smooth muscle cell proliferation induced by thermal injury with pulsed infrared lasers (1992) (38)
Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. (2015) (38)
Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials. (2020) (37)
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
Stress Testing in Asymptomatic Aortic Stenosis (2017) (37)
Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy. (1998) (37)
701-5 Endovascular Stents Reduce Restenosis by Eliminating Geometric Arterial Remodeling: A Serial Intravascular Ultrasound Study (1995) (37)
Impact of the COVID‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter (2020) (37)
Transient contrast encephalopathy after carotid artery stenting. (2001) (37)
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients. (2018) (37)
Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis (2017) (36)
935-32 Differing Mechanisms of Late Arterial Responses to Transcatheter Therapy: A Serial Quantitative Angiographic and Intravascular Ultrasound Study (1995) (36)
Transcatheter Therapy for Mitral Regurgitation Clinical Challenges and Potential Solutions (2017) (36)
Percutaneous paravalvular leak closure: chasing the chameleon. (2016) (36)
The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension. (2020) (36)
Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry. (2019) (36)
Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention: Technique Analysis From the EXCEL Trial (2018) (36)
Augmentation of the expression of proangiogenic genes in cardiomyocytes with low dose laser irradiation in vitro. (1999) (36)
Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. (2001) (36)
Injuries to the Aorta, Aortic Annulus, and Left Ventricle During Transcatheter Aortic Valve Replacement: Management and Outcomes. (2017) (36)
Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. (2000) (35)
Subarachnoidal hemorrhage following carotid stenting with the distal‐balloon protection (2001) (35)
Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial (2002) (35)
In vivo human atherosclerotic plaque recognition by laser-excited fluorescence spectroscopy. (1991) (35)
Post–Market Approval Surveillance: A Call for a More Integrated and Comprehensive Approach (2004) (35)
Granulomatous 'foreign body reactions' contribute to exaggerated in-stent restenosis. (1999) (35)
CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. (2017) (35)
Restenosis due to underexpansion of sirolimus‐eluting stent in a bifurcation lesion (2003) (35)
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic (2020) (35)
Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. (2015) (35)
Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. (2016) (34)
Chronic total obstruction and short-term outcome: the Excimer Laser Coronary Angioplasty Registry experience. (1993) (34)
Advanced c‐myc antisense (AVI‐4126)‐eluting phosphorylcholine‐coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model (2004) (34)
Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. (2000) (34)
In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system. (2016) (34)
Intravascular ultrasound diagnosis of a coronary artery pseudoaneurysm following percutaneous transluminal coronary angioplasty. (1993) (34)
Acute and chronic effects of self-expanding nitinol stents in porcine coronary arteries. (1997) (33)
Embolization via Collateral Circulation during Carotid Stenting with the Distal Balloon Protection System (2001) (33)
The Tiara transcatheter mitral valve implantation system. (2015) (33)
Feasibility and safety of percutaneous laser revascularization using the BiosenseTM system in porcine hearts (1998) (33)
Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve-in-Valve Procedures. (2015) (33)
Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial. (1999) (33)
Successful use of the frontrunner catheter in the treatment of in‐stent coronary chronic total occlusions (2004) (33)
Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent. (2009) (33)
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). (2010) (33)
Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients. (2013) (33)
Challenges and future opportunities for transcatheter aortic valve therapy. (2014) (33)
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (33)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies (2005) (33)
Intracoronary stents. A breakthrough technology or just another small step? (1994) (32)
Altered compliance and residual strain precede angiographically detectable early atherosclerosis in low-density lipoprotein receptor deficiency. (1997) (32)
Current perspectives on direct myocardial revascularization. (1998) (32)
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study. (2020) (32)
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. (2022) (32)
Optimizing Cardiac CT Protocols for Comprehensive Acquisition Prior to Percutaneous MV and TV Repair/Replacement. (2020) (32)
Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent (2001) (32)
Procedural and follow up results with a new balloon expandable stent in unselected lesions (1998) (32)
Vascular response to sirolimus‐eluting stents delivered with a nonaggressive implantation technique: Comparison of intravascular ultrasound results from the multicenter, randomized E‐SIRIUS, and SIRIUS trials (2005) (32)
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. (2003) (32)
Transcatheter aortic valve replacement program development: Recommendations for best practice (2014) (32)
Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement. (2018) (31)
Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. (2011) (31)
Very low intravenous contrast volume protocol for computed tomography angiography providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic kidney disease. (2016) (31)
Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial. (2018) (31)
Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. (2014) (31)
Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. (2010) (31)
Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible? (2010) (31)
Inter-core lab variability in analyzing quantitative coronary angiography for bifurcation lesions: a post-hoc analysis of a randomized trial. (2015) (31)
Intravascular ultrasound-guided renal artery stenting. (2001) (31)
Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial. (2020) (31)
Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. (2018) (31)
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. (2021) (31)
Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). (2014) (31)
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). (2002) (31)
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention. (2007) (31)
Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. (2002) (31)
Impact of stents on clinical outcomes in percutaneous left main coronary artery revascularization. (1998) (31)
Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease. (2004) (31)
Update on drug-eluting coronary stents (2005) (31)
Serial Intravascular Ultrasound Analysis of the Impact of Lesion Length on the Efficacy of Intracoronary &ggr;-Irradiation for Preventing Recurrent In-Stent Restenosis (2001) (30)
Cost-effectiveness of sirolimus drug-eluting stents for the treatment of complex coronary stenoses: Results from the randomized SIRIUS trial (2003) (30)
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings. (2011) (30)
Effect of Short Pulsed Nonablative Infrared Laser Irradiation on Vascular Cells In Vitro and Neointimal Hyperplasia in a Rabbit Balloon Injury Model (2001) (30)
Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. (1994) (30)
Effect of preintervention plaque burden on subsequent intimal hyperplasia in stented coronary artery lesions. (2000) (30)
Acute and long-term results of an intravascular ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy. (1999) (30)
Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease. (2020) (30)
Moderate Aortic Stenosis and Heart Failure With Reduced Ejection Fraction: Can Imaging Guide Us to Therapy? (2019) (30)
Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety. (2016) (30)
Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting. (2000) (30)
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention. (2020) (30)
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. (2019) (30)
Local delivery of c‐myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury model (2001) (30)
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. (2002) (29)
Immediate procedural and long-term clinical results of internal mammary artery angioplasty. (1992) (29)
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. (2018) (29)
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. (2006) (29)
Intravascular ultrasound findings in stenting of unprotected left main coronary artery stenosis. (1998) (28)
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
Intravascular ultrasound identification of calcified intraluminal lesions misdiagnosed as thrombi by coronary angiography. (1996) (28)
Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement (2015) (28)
First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial. (2012) (28)
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. (2014) (28)
An in vivo feasibility study of intravascular ultrasound imaging. (1989) (28)
Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry. (2009) (28)
The Tryton Side Branch Stent. (2010) (28)
Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. (1995) (28)
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. (2003) (28)
Practical determination of aortic valve calcium volume score on contrast-enhanced computed tomography prior to transcatheter aortic valve replacement and impact on paravalvular regurgitation: Elucidating optimal threshold cutoffs. (2017) (28)
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience. (1997) (28)
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19 (2020) (28)
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program (2013) (28)
The role of mucomyst administration prior to percutaneous interventions on renal function in patients with chronic renal failure (2002) (28)
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future. (2010) (27)
Intravascular Ultrasound–Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions (2021) (27)
Perspectives of Drug-Eluting Stents (2002) (27)
Multi-center registry of percutaneous coronary rotational ablation using the rotablator (1991) (27)
Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry. (2019) (27)
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries. (2019) (27)
A large coronary artery saphenous vein bypass graft aneurysm with a fistula: Case report and review of the literature (1999) (27)
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. (1999) (27)
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (27)
Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. (2004) (27)
Images in cardiovascular medicine. Cantrell's syndrome: left ventricular diverticulum in an adult patient. (2000) (27)
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. (2006) (27)
Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. (1997) (27)
Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy. (1989) (26)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk. (2021) (26)
Trends in Usage and Clinical Outcomes of Coronary Atherectomy (2020) (26)
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Randomized Trials (2020) (26)
Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients. (2018) (26)
Comparison between Three‐Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies (2018) (26)
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies. (2018) (26)
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes. (2021) (26)
Brain Injury After Transcatheter Replacement of Bicuspid Versus Tricuspid Aortic Valves. (2020) (26)
The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems (2007) (26)
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. (2010) (26)
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. (2003) (25)
Value of drug-eluting stents in cardiac transplant recipients. (2009) (25)
Cardiopulmonary bypass and intra‐aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy (2015) (25)
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. (2004) (25)
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. (2020) (25)
Transient Contrast Encephalopathy after Carotid Artery Stenting (2001) (25)
Health after coronary stenting or balloon angioplasty: results from the Stent Restenosis Study. (1997) (25)
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. (2021) (25)
Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study (2016) (25)
Long‐term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 Years) (2013) (25)
Balloon expandable stent implantation in stenotic right heart valved conduits. (1990) (25)
Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study. (2016) (25)
Tissue characterisation of atherosclerotic plaque in coronary artery bifurcations: an intravascular ultrasound radiofrequency data analysis in humans. (2010) (25)
Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. (2004) (25)
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. (2020) (25)
Perspectives on antisense therapy for the prevention of restenosis. (2001) (24)
Comparison of Transcatheter and Surgical Aortic Valve Replacement in Severe Aortic Stenosis: A Longitudinal Study of Echo Parameters in Cohort A of the PARTNER Trial (2013) (24)
Impact of Methodologic Differences in Three‐Dimensional Echocardiographic Measurements of the Aortic Annulus Compared with Computed Tomographic Angiography Before Transcatheter Aortic Valve Replacement (2017) (24)
Left main drug-eluting stents: natural progression or a bridge too far? (2007) (24)
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. (2003) (24)
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis (2018) (24)
Use of intracoronary ultrasound to identify the "true" coronary lumen in chronic coronary dissection treated with intracoronary stenting. (1992) (24)
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque. (2005) (24)
Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A. (2017) (24)
Failure or success of complex catheter-based interventional procedures assessed by intravascular ultrasound. (1992) (24)
Late thrombosis a concern with drug-eluting stents. (2007) (23)
Update on sirolimus drug-eluting stents. (2004) (23)
Safety of Intracoronary γ-Radiation on Uninjured Reference Segments During the First 6 Months After Treatment of In-Stent Restenosis A Serial Intravascular Ultrasound Study (2000) (23)
Characterization of atherosclerotic lesions by intravascular ultrasound: possible role in unstable coronary syndromes and in interventional therapeutic procedures. (1991) (23)
Diagnosis and management of aortic valve stenosis in patients with heart failure (2016) (23)
Transcatheter Aortic and Mitral Valve‐in‐Valve Implantation Using the Edwards Sapien 3 Heart Valve (2018) (23)
Percutaneous Transmyocardial Laser Revascularization: An Overview (1999) (23)
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. (2019) (23)
Effect of rotational atherectomy in noncalcified atherosclerotic plaque: a volumetric intravascular ultrasound study. (1996) (23)
Determinants of ventricular arrhythmias in mildly symptomatic patients with coronary artery disease and influence of inducible left ventricular dysfunction on arrhythmia frequency. (1987) (23)
Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry Report). (2000) (23)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (23)
Evolving strategies for the treatment of valvular heart disease: Preclinical and clinical pathways for percutaneous aortic valve replacement (2008) (23)
Left ventricular pulsus alternans in patients with hypertrophic cardiomyopathy and severe obstruction to left ventricular outflow. (1986) (23)
Analysis of verapamil in plasma by liquid chromatography. (1980) (23)
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study. (2012) (22)
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). (2017) (22)
Patient selection for transcatheter aortic valve replacement. (2013) (22)
Studies on the histogenesis of myxomatous tissue of human coronary lesions. (1999) (22)
Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. (2001) (22)
Restenosis after Palmaz-Schatz™ Stent Implantation (1992) (22)
First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study. (2007) (22)
Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy (2015) (22)
New-Device Angioplasty in Women: Clinical Outcome and Predictors in a 7,372-Patient Registry (2002) (22)
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (22)
An overview of US coronary stent trials. (1996) (22)
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. (2002) (22)
Effect of Functional Mitral Regurgitation on Outcome in Patients Receiving Cardiac Resynchronization Therapy for Heart Failure. (2019) (22)
A virtual histology intravascular ultrasound analysis of coronary chronic total occlusions (2013) (22)
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacement. (2016) (22)
Incremental value of left ventricular global longitudinal strain in a newly proposed staging classification based on cardiac damage in patients with severe aortic stenosis. (2020) (22)
Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry. (1997) (22)
Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery. (2002) (22)
Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention. (2012) (21)
Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes. (2000) (21)
In vitro and in vivo intravascular ultrasound imaging. (1992) (21)
Novel site‐specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model (2005) (21)
One-year clinical outcome after minimally invasive direct coronary artery bypass. (2000) (21)
Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy. (1985) (21)
Coronary intervention in the diabetic patient: Improved outcome following stent implantation compared with balloon angioplasty (2002) (21)
Patient radiation exposure during transcatheter aortic valve replacement procedures. (2012) (21)
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure (2022) (21)
Competency-Based Assessment of Interventional Cardiology Fellows' Abilities in Intracoronary Physiology and Imaging. (2020) (21)
The axial distribution of lesion-site atherosclerotic plaque components: an in vivo volumetric intravascular ultrasound radio-frequency analysis of lumen stenosis, necrotic core and vessel remodeling. (2009) (21)
Restorative valve therapy by endogenous tissue restoration: tomorrow's world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration. (2017) (21)
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. (2001) (20)
New device angioplasty: the impact on restenosis. (1993) (20)
Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (2017) (20)
Inter-series differences in the restenosis rate of Palmaz-Schatz coronary stent placement: differences in demographics and post-procedure lumen diameter. (1994) (20)
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). (2003) (20)
Comparative effects of verapamil and nitroprusside on left ventricular function in patients with hypertension. (1989) (20)
Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations. (2002) (20)
Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort. (2013) (20)
Functional Properties of a Prototype Rheolytic Catheter for Percutaneous Thrombectomy: In Vitro Investigations (1994) (20)
Biomarkers in Aortic Stenosis: A Systematic Review (2017) (20)
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis (2019) (20)
Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. (2018) (20)
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. (2003) (20)
A novel platinum‐iridium, potentially gamma radioactive stent: Evaluation in a porcine model (2000) (20)
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis. (2021) (19)
Diabetes mellitus is associated with plaque classified as thin cap fibroatheroma: an intravascular ultrasound study (2010) (19)
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. (2019) (19)
Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions. (2017) (19)
Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). (2011) (19)
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. (2006) (19)
Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry. (2009) (19)
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial (2017) (19)
Transcatheter aortic valve replacement and vascular complications definitions. (2014) (19)
Anti-angiogenesis: A new potential strategy to inhibit restenosis. (2001) (19)
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
Paravalvular leak after transcatheter aortic valve replacement. (2013) (19)
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. (2018) (19)
One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stent. (2013) (19)
Randomized, double‐blind, multicenter study of the polymer‐based 17‐β estradiol‐eluting stent for treatment of native coronary artery lesions: Six‐month results of the ETHOS I trial (2007) (18)
Interrelation of coronary angiographic reference lumen size and intravascular ultrasound target lesion calcium. (1998) (18)
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. (2003) (18)
Atherosclerotic saphenous vein grafts treated with different interventional procedures assessed by intravascular ultrasound. (1992) (18)
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%. (2003) (18)
Evaluating Medical Therapy for Calcific Aortic Stenosis (2021) (18)
Intravascular ultrasound assessment of the relation between early and late changes in arterial area and neointimal hyperplasia after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. (1999) (18)
Strategies for acute occlusion after coronary angioplasty. (1992) (18)
The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and (2007) (18)
Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right (2015) (18)
Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era (2020) (18)
Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results. (2021) (18)
Performance of the resolute zotarolimus‐eluting stent in small vessels (2014) (18)
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. (2021) (18)
Transcatheter Aortic Valve Replacement by a Novel Suprasternal Approach. (2018) (18)
The SIRIUS‐DIRECT trial: A multi‐center study of direct stenting using the sirolimus‐eluting stent in patients with de novo native coronary artery lesions (2007) (18)
Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire. (1998) (18)
Laser Sources for Angioplasty (1990) (18)
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. (2020) (18)
Successful treatment of angina pectoris with liver transplantation and bilateral internal mammary bypass graft surgery in familial hypercholesterolemia. (1988) (18)
Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. (2003) (17)
Sex‐specific outcomes following revascularization with zotarolimus‐eluting stents: Comparison of angiographic and late‐term clinical results (2010) (17)
Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). (2016) (17)
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. (2003) (17)
Transcatheter tricuspid valve-in-valve replacement resulting in 4 different prosthetic heart valves in a single patient. (2013) (17)
Coronary artery stenting (2002) (17)
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. (2002) (17)
Aortic Valve Annular Sizing: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography (2017) (17)
Pathology of balloon‐expandable transcatheter aortic valves (2017) (17)
Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry. (2005) (17)
Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry. (1997) (17)
Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS Coronary Radiation to Inhibit Proliferation Post Stenting trial. (1996) (17)
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). (2014) (16)
Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. (2019) (16)
Sirolimus-eluting stents in bifurcation lesions: Six-month angiographic results according to the implantation technique (2003) (16)
Cardiovascular and Noncardiovascular Death After Percutaneous Coronary Intervention: Insights From 32 882 Patients Enrolled in 21 Randomized Trials (2018) (16)
Rat model of veno-arterial extracorporeal membrane oxygenation (2014) (16)
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). (2006) (16)
Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts. (2000) (16)
Restenosis after coronary angioplasty. (1997) (16)
Prevalence and anatomical features of acute longitudinal stent deformation: An intravascular ultrasound study (2014) (16)
Development of a novel calcified total occlusion model in porcine coronary arteries. (2008) (16)
Pulmonary Artery Denervation Using Catheter based Ultrasonic Energy. (2019) (16)
Contemporary stent designs: technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy. (1996) (16)
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials (2019) (16)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis (2016) (16)
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents (2020) (16)
Left ventricular systolic dysfunction diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. (1995) (16)
A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in‐stent restenosis (1997) (16)
Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. (2001) (16)
The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies (2021) (15)
Prognostic Implications of Associated Cardiac Abnormalities Detected on Echocardiography in Patients With Moderate Aortic Stenosis. (2021) (15)
Pulsed laser and thermal ablation of atherosclerotic plaque: morphometrically defined surface thrombogenicity in studies using an annular perfusion chamber. (1992) (15)
Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model. (2003) (15)
Angioplasty in a child with Kawasaki disease. (1992) (15)
Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. (2006) (15)
Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes (2018) (15)
Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United States. (2016) (15)
Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. (2003) (15)
Intravascular ultrasound assessment of biliary stent implantation in saphenous vein grafts. (1995) (15)
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement: PARTNER 3 Trial. (2021) (15)
Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints (2019) (15)
An update on the clinical use of drug-coated balloons in percutaneous coronary interventions (2016) (15)
Leaflet immobility and thrombosis in transcatheter aortic valve replacement (2020) (15)
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. (2022) (15)
Serial gray scale intravascular ultrasound findings in late drug-eluting stent restenosis. (2013) (15)
An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries. (2012) (15)
Evaluation of a Novel Endoluminal Vascular Occlusion Device in a Porcine Model: Early and Late Follow-up (2005) (14)
Problems in the evaluation of new devices for coronary intervention: what have we learned since 1989? (1997) (14)
Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery. (1995) (14)
Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial). (2014) (14)
Occlusive peripheral vascular disease: a multicenter trial of fluorescence-guided, pulsed dye laser-assisted balloon angioplasty. (1991) (14)
In vivo intravascular ultrasonic assessment of anomalous right coronary artery arising from left coronary sinus. (2009) (14)
Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture. (2006) (14)
Vascular effects of diet-induced hypercalcemia after balloon artery injury in giant Flemish rabbits. (1995) (14)
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial (2022) (14)
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. (2003) (14)
Intracoronary radiation for patients with refractory in-stent restenosis: an analysis from the WRIST-Crossover Trial. Washington Radiation for In-stent Restenosis Trial. (1999) (14)
Mechanism of lumen gain with a novel rotational aspiration atherectomy system for peripheral arterial disease: examination by intravascular ultrasound. (2010) (14)
Intracoronary ultrasound is an improved technique to assess acute and chronic changes after stent placement (1991) (14)
Percutaneous transcatheter management of giant coronary aneurysms. (1999) (14)
Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. (2005) (14)
Luminal narrowing due to intramural hematoma shift from left anterior descending coronary artery to left circumflex artery (2004) (13)
Early and late healing responses of normal canine artery to excimer laser irradiation. (1988) (13)
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study). (2005) (13)
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. (2018) (13)
Electromechanical characterization of acute experimental myocardial infarction. (1999) (13)
Risk stratification of patients undergoing medical therapy after coronary angiography. (2016) (13)
Mechanisms and immediate and long-term results of adjunct directional coronary atherectomy after rotational atherectomy. (1996) (13)
Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents. (2010) (13)
Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey. (1998) (13)
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial. (2018) (13)
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part€2: Endpoint Definitions (2017) (13)
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies. (2016) (13)
Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers. (2002) (13)
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). (2007) (12)
Late (two-year) follow-up from the First-In-Man (FIM) experience after implantation of sirolimus-eluting stents (2002) (12)
Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial (2013) (12)
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. (2022) (12)
Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. (2000) (12)
701-2 The Final % Cross-sectional Narrowing (Residual Plaque Burden) is the Strongest Intravascular Ultrasound Predictor of Angiographic Restenosis (1995) (12)
Enhanced stent imaging improves the diagnosis of stent underexpansion and optimizes stent deployment (2011) (12)
Handbook of Myocardial Revascularization and Angiogenesis (1999) (12)
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement (2020) (12)
The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials. (2019) (12)
Long‐term efficacy and safety of zotarolimus‐eluting stent in patients with diabetes mellitus: Pooled 5‐year results from the ENDEAVOR III and IV trials (2013) (12)
The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database. (2020) (12)
Importance of lesion length on new device angioplasty of native coronary arteries (2000) (12)
Medical and surgical therapy of hypertrophic cardiomyopathy. (1988) (12)
One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with denovo native coronary artery lesions (2003) (12)
Impact of body mass index on long‐term clinical outcomes after second‐generation drug eluting stent implantation: Insights from the international global RESOLUTE program (2015) (12)
Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries. (1996) (12)
Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement (2019) (12)
Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries (2020) (12)
Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation. (2005) (12)
Lack of association of intermediate CPK-MB elevation and late mortality in patients treated with intracoronary stents (1998) (12)
First-in-Human Results of a Novel User-Friendly Transcatheter Edge-to-Edge Mitral Valve Repair Device. (2019) (11)
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings (2010) (11)
Atrial Fibrillation is Associated with Increased Pacemaker Implantation Rates in the Placement of AoRTic Transcatheter Valve (PARTNER) Trial. (2017) (11)
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. (2003) (11)
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. (2022) (11)
Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement. (2019) (11)
Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model. (2002) (11)
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial. (2018) (11)
Morphologic findings in stenotic aortic valves that have had "successful" percutaneous balloon valvuloplasty. (1988) (11)
Immediate results and late clinical outcomes after new CrossFlex coronary stent implantation. (1999) (11)
Safety and efficacy of a novel abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent for the treatment of de novo coronary lesions: Two‐year results from a prospective patient‐level pooled analysis of TARGET trials (2015) (11)
Sex Disparities in Patients with Symptomatic Severe Aortic Stenosis. (2021) (11)
S-nitrosoglutathione reduces nonocclusive thrombosis rate following balloon overstretch injury and intracoronary irradiation of porcine coronary arteries. (2000) (11)
Intravascular ultrasound of coronary atherectomy (1991) (11)
Suprasternal and Left Axillary Transcatheter Aortic Valve Replacement in Morbidly Obese Patients. (2018) (11)
CRUISE: can routine intravascular ultrasound influence stent expansion? Analysis of outcomes (1998) (11)
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (11)
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States. (2021) (11)
Imaging in patients with severe mitral annular calcification: insights from a multicentre experience using transatrial balloon-expandable valve replacement. (2019) (11)
Mitral Valve Regurgitation and Left Ventricular Dysfunction Treatment with an Intravalvular Spacer (2015) (11)
Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. (2022) (11)
Frequency and determinants of black holes in sirolimus-eluting stent restenosis. (2006) (11)
Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women (2005) (11)
Upcoming TAVI trials: rationale, design and impact on clinical practice. (2016) (11)
TCT-236 Effects of Orbital Versus Rotational Atherectomy Facilitated PCI on the Coronary Microcirculation. (2016) (11)
Comparison of results of rotational coronary atherectomy in three age groups (< 70, 70 to 79 and > or = 80 years). (1993) (11)
Predictors of late mortality following ablative new-device angioplasty in native coronary arteries (1996) (11)
Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound. (2004) (11)
Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation. (2021) (11)
Laser Myocardial Revascularization Modulates Expression of Angiogenic, Neuronal, and Inflammatory Cytokines in a Porcine Model of Chronic Myocardial Ischemia (2001) (11)
Safety and efficacy of a novel abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent for the treatment of de novo coronary lesions: 12‐month results from the TARGET II trial (2014) (11)
Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions (2002) (10)
Intra-arterial reteplase for the treatment of acute limb ischemia. (1999) (10)
The evolving role of coronary angiography and fluoroscopy in cardiac diagnosis and intervention. (2007) (10)
Paravalvular Regurgitation Following Transcutaneous Aortic Valve Replacement: Predictors and Clinical Significance (2014) (10)
Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT). (1999) (10)
An intravascular ultrasound comparison of left anterior descending artery/first diagonal branch versus distal left main coronary artery bifurcation lesions. (2013) (10)
Comparison between two‐ and three‐dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial (2015) (10)
The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent (2016) (10)
Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension: Insights From the TriValve Registry. (2021) (10)
Concomitant transcatheter aortic and mitral valve-in-valve replacements using transfemoral devices via the transapical approach: first case in United States. (2013) (10)
Intracoronary radiation therapy for patients with in-stent restenosis. Interim report from a randomized clinical study (1998) (10)
Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis (2012) (10)
Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial. (2015) (10)
[Percutaneous artificial heart valves: from animal experimentation to the first human implantation in a case of calcified aortic stenosis]. (2003) (10)
Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes. (2020) (10)
Virtual histology intravascular ultrasound comparison of coronary chronic total occlusions versus non-occlusive lesions (2013) (10)
Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN‐CTO registry (2020) (10)
Direct infusion of fenoldopam into the renal arteries to protect against contrast‐induced nephropathy in patients at increased risk (2012) (10)
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. (2010) (10)
Consensus Document on Non-Suitability for Transcatheter Mitral Valve Repair by Edge-to-Edge Therapy (2021) (10)
Erratum: Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. J Am Coll Cardiol Intv 2011;4:97481 (2011) (10)
Platelet adherence and thrombus formation with flowing human blood on atherosclerotic plaque: reduced thrombogenicity of Watanabe-heritable hyperlipidemic rabbit aortic subendothelium. (1989) (10)
Catheter‐based electromechanical mapping to assess regional myocardial function: A comparative analysis with transthoracic echocardiography (2001) (10)
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial. (2018) (10)
Photoactivation of Vascular iNOS and Elevation of cGMP In Vivo: Possible Mechanism for Photovasorelaxation and Inhibition of Restenosis in an Atherosclerotic Rabbit Model ¶ (2000) (10)
Integrating Quality of Life and Survival Outcomes Cardiovascular Clinical Trials. (2019) (10)
Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry. (2018) (10)
Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus. (1999) (10)
Intravascular ultrasound findings after excimer laser coronary angioplasty. (1996) (10)
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents (2008) (10)
Impact of Local Anesthesia Only Versus Procedural Sedation Using the Vancouver Clinical Pathway for TAVR: Insights From the 3M TAVR Study. (2019) (10)
Short-term clinical results and complications with the palmaz-schatz coronary stent (1990) (10)
Improving the accuracy of effective orifice area assessment after transcatheter aortic valve replacement: validation of left ventricular outflow tract diameter and pulsed-wave Doppler location and impact of three-dimensional measurements. (2015) (10)
Early and late quantitative angiographic outcomes in the optimal atherectomy restenosis study (OARS) (1996) (9)
Visual estimation versus different quantitative coronary angiography methods to assess lesion severity in bifurcation lesions (2018) (9)
Clinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19 (2021) (9)
Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention (2009) (9)
Can coronary flow parameters after stent placement predict restenosis? (1995) (9)
Is intravascular ultrasound clinically useful or is it just a research tool? (1997) (9)
Transcatheter Aortic-Valve Replacement. (2016) (9)
Intravascular ultrasound, directional coronary atherectomy, and the Optimal Atherectomy Restenosis Study (OARS). (1996) (9)
Transcatheter device synergy: preliminary experience with adjunct directional coronary atherectomy following high-speed rotational atherectomy or excimer laser angioplasty in the treatment of coronary artery disease. (1993) (9)
Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease (2020) (9)
Late, out-of-laboratory, abrupt closure after angiographically successful directional coronary atherectomy. (1992) (9)
Safety of intracoronary gamma-radiation on uninjured reference segments during the first 6 months after treatment of in-stent restenosis: a serial intravascular ultrasound study. (2000) (9)
Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation. (2018) (9)
Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval (2016) (9)
Bypass to the left coronary artery system may accelerate left main coronary artery negative remodeling and calcification (2013) (9)
Transcatheter aortic valve replacement: a breakthrough medical therapy! The 20-year odyssey, and now, a 10-year anniversary. (2012) (9)
Intravascular Ultrasound—Guided Renal Artery Stenting (2001) (9)
TCT-446 Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (≥75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry (2012) (9)
Use of stented bovine pericardial valve for surgical mitral valve replacement in infants. (2016) (9)
Transcatheter aortic valve replacement in patients with bicuspid aortic valves. (2018) (9)
Echocardiographic assessment of pressure volume relations in heart failure and valvular heart disease: using imaging to understand physiology. (2011) (9)
Feasibility and efficacy of locally delivered enoxaparin via the Channeled Balloon catheter on smooth muscle cell proliferation following balloon injury in rabbits. (1997) (9)
710-2 Coronary Stents Versus Balloon Angioplasty for Aorto-Coronary Saphenous Vein Bypass Graft Disease: Interim Results of a Randomized Trial (1995) (9)
A dual-purpose angioplasty-drug infusion catheter for the treatment of intragraft thrombus. (1994) (9)
Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes: A Systematic Review and Meta-Analysis. (2022) (9)
Clinical use of sirolimus-eluting stents. (2007) (8)
Prognostic value of recurrent episodes of creatine kinase‐MB elevation following repeated catheter‐based coronary interventions (2000) (8)
Benefits of cutting balloon before stenting. (2003) (8)
THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT (2013) (8)
Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right (2015) (8)
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registry. (1997) (8)
Photoactivation of Vascular iNOS and Elevation of cGMP In Vivo: Possible Mechanism for Photovasorelaxation and Inhibition of Restenosis in an Atherosclerotic Rabbit Model¶ (2000) (8)
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence. (2020) (8)
Low-power laser irradiation increases cyclic GMP synthesis in penile smooth muscle cells in vitro. (2000) (8)
REDUCED INCIDENCE OF PROSTHESIS–PATIENT MISMATCH AND ITS SEQUELAE IN TRANSCATHETER VERSUS SURGICAL VALVE REPLACEMENT IN HIGH–RISK PATIENTS WITH SEVERE AORTIC STENOSIS: A PARTNER TRIAL COHORT A ANALYSIS (2013) (8)
Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic Review (2021) (8)
Intravascular ultrasound characteristics of atheroma in angiographically “normal” segments (1991) (8)
Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes. (1998) (8)
Percutaneous Coronary Intervention With Bioresorbable Scaffolds in a Young Child (2017) (8)
Peri-Device Leaks after Percutaneous Left Atrial Appendage Closure: Clinical Significance and Unmet Diagnostic Needs (2020) (8)
First clinical experience with 17- estradiol-eluting biodivYsio matrix LO stent to prevent restenosis in de-novo native coronary arteries: Six-month clinical outcomes and angiographic follow-up from the EASTER trial (2003) (8)
Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound (2000) (8)
Use of the sirolimus-eluting Bx VELOCITYtmstent for failed brachytherapy in recurrent in-stent restenosis: Results from the SECURE Registry (2003) (8)
APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction--rationale and design. (2014) (8)
A translational "humanised" porcine model for transcatheter mitral valve interventions: the neo inferior vena cava approach. (2015) (8)
- year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis ( PARTNER 1 ) : a randomised controlled trial (2015) (8)
Excimer laser angioplasty in the treatment of instent restenosis: An intravascular ultrasound study (1996) (8)
Optimally deployed stents in the treatment of restenotic versus de novo lesions. (2000) (8)
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions (2020) (8)
The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go? (2018) (8)
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial. (2018) (8)
Abstract of original contributions to be presented at the American College of Cardiology 52nd Annual Scientific Session, March 30–April 2, 2003, Chicago, Illinois Angiography and interventional cardiology (2003) (8)
Impact of directional atherectomy on adjacent branch vessels. (1993) (8)
Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis (2017) (8)
Recanalization of chronic total coronary occlusions using a laser guide wire: The Eu and US total experience (1996) (7)
Saline infusion via local drug delivery catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model. (1999) (7)
Primary coronary angioplasty in patients with acute myocardial infarction. (1994) (7)
Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty. (2000) (7)
Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach (2020) (7)
Vascular stent deployment in vein bypass grafts: observations in an animal model. (1994) (7)
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses. (2022) (7)
Intravascular ultrasonography: validation studies and preliminary intraoperative observations. (1991) (7)
Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial (2018) (7)
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease (2021) (7)
Neuroprotection reduces the risk of peri-procedural major strokes and death in octogenarians (2002) (7)
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program. (2016) (7)
Differential Impact of Stent versus PTCA on Restenosis in Large (≥3 mm) and Small <3 mm) Vessels in the STent REStenosis Study (1995) (7)
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease. (2022) (7)
Influence of guiding catheter selection on the measurement of coronary flow reserve. (1997) (7)
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial. (2003) (7)
Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients. (2020) (7)
Classification for Assessing the Quality of Diagnostic Coronary Angiography. (2017) (7)
The impact of sirolimus-eluting stents in diabetics: Results from the SIRIUS trial (2003) (7)
Transcatheter aortic valve replacement. (2011) (7)
MITRAL REGURGITATION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION FOR DEGENERATED SURGICAL AORTIC BIOPROSTHESIS: INSIGHTS FROM PARTNER 2 VALVE-IN-VALVE REGISTRY (2018) (7)
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy. (2016) (7)
Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization (2022) (7)
Treatment of refractory coronary occlusions with a new excimer laser catheter: Preliminary clinical observations (1993) (7)
Fibroblast growth factors are expressed in coronary lesions of patients with unstable angina pectoris and those who have post angioplasty restenosis (1991) (7)
Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial. (2019) (7)
Transcatheter Aortic Valve Replacement: 2015 in Review. (2016) (7)
ascular Complications Associated With rteriotomy Closure Devices in Patients ndergoing Percutaneous Coronary Procedures (2016) (7)
Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms (2019) (7)
862-1 Matched comparison of direct stenting to predilation with the sirolimus-eluting by velocity™ stent (2004) (7)
Electrical thermal angioplasty: catheter design features, in vitro tissue ablation studies and in vivo experimental findings. (1987) (7)
von Willebrand Disease After TAVR: The Missing Link? (2015) (7)
Abrupt closure following rotational ablation with the rotablator — Short term clinical follow up (1991) (6)
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2019) (6)
Improvement in left ventricular function following higher‐risk percutaneous coronary intervention in patients with ischemic cardiomyopathy (2020) (6)
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy. (2003) (6)
Association Between Patient Survival and Clinician Variability in Treatment Rates for Aortic Valve Stenosis (2021) (6)
Hemodynamic and clinical effects of combined therapy with verapamil and propranolol in ischemic heart disease (1984) (6)
Favorable results of debulking followed by immediate adjunct stent therapy for high risk saphenous vein graft lesions (1996) (6)
Integrated minimally invasive approaches for the treatment of atherosclerotic vascular diseases: Hybrid procedures (2001) (6)
TCT-688 One Year Results of Tanscatheter Aortic Valve Therapy for Failed Surgical Bioprostheses - PARTNER II Valve-in-Valve Registry (2014) (6)
Late clinical outcomes of cordis tantalum coronary stenting without anticoagulation. (1997) (6)
Standardized Invasive Hemodynamics for Management of Patients With Elevated Echocardiographic Gradients Post-Transcatheter Aortic Valve Replacement at Midterm Follow-Up. (2021) (6)
Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement (2021) (6)
Successful Directional Atherectomy of De Novo Coronary Lesions Assessed With Three-Dimensional Intravascular Ultrasound and Angiographic Follow-Up (1997) (6)
Predictors of clinical outcome following NIR stent implantation for coronary artery disease: analysis of the results of the First International New Intravascular Rigid-Flex Endovascular Stent Study (FINESS trial). (2002) (6)
Sirolimus-eluting stent for the treatment of bypass graft disease: The initial U.S. Experience (2003) (6)
RATES OF PARAVALVULAR AORTIC REGURGITATION WITH MDCT NOMINAL AREA OVERSIZING OR UNDERSIZING AFTER TRANSCATHETER HEART VALVE REPLACEMENT WITH THE SAPIEN 3: A COMPARISON WITH THE SAPIEN XT (2014) (6)
901-21 Percutaneous Vascular Surgery: Suture Mediated Percutaneous Closure of Femoral Artery Access Site Following Coronary Intervention (1995) (6)
Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization. (2000) (6)
Clinical experience with stent implantation in the treatment of saphenous vein graft lesions. (1994) (6)
Simultaneous Assessment of Coronary Flow Reserve and Fractional Flow Reserve with a Novel Pressure-Based Method (2000) (6)
Clinical utility of plasma verapamil levels in patients with hypertrophic cardiomyopathy (1981) (6)
Intravascular ultrasound imaging in a patient with unstable angina. (1992) (6)
864-3 Transendocardial autologous bone marrow cell transplantation in patients with advanced ischemic heart disease: Final results from a multi-center feasibility study (2004) (6)
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: Results from the CADILLAC trial (2008) (6)
The frequency and consequences of angiographic aneurysms after sirolimus-eluting stents: Results from SIRIUS (2003) (6)
Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve (2021) (6)
Assessing the risk of aortic valve replacement for severe aortic stenosis in the transcatheter valve era. (2014) (6)
Patterns of in-stent restenosis Classification and impact on subsequent target lesion revascularization (1998) (6)
Intravascular ultrasound assessment of plaque responses to PCTA helps to explain angiographic findings (1991) (6)
Association of Volume and Outcomes in 234,556 Patients Undergoing Surgical Aortic Valve Replacement. (2021) (6)
Endothelial dysfunction after drug-eluting stent was never predicted in preclinical studies. (2006) (6)
Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial (2015) (6)
Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply. (2019) (6)
Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial (2017) (6)
Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3. (2021) (6)
909-25 Clinical Outcomes of Patients not Undergoing Coronary Artery Revascularization as a Result of Intravascular Ultrasound Imaging (1995) (6)
Updating an institutional chest pain algorithm: incorporating new evidence on emerging pharmacotherapy. (2012) (6)
The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective. (2012) (6)
Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy (2018) (6)
Successful directional atherectomy of de novo coronary lesions assessed with three-dimensional intravascular ultrasound and angiographic follow-up. (1997) (6)
A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch (2013) (6)
Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study. (2021) (6)
Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES). (2016) (5)
Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomy. (2001) (5)
Anatomic classification of mitral annular calcification for surgical and transcatheter mitral valve replacement (2021) (5)
Discordant severity criteria in patients with moderate aortic stenosis: prognostic implications (2021) (5)
Effects of sirolimus-eluting stents in diabetic patients: Volumetric intravascular ultrasound analysis from the SIRIUS trial (2003) (5)
Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies (2020) (5)
Atrial Fibrillation and Outcomes After Transcatheter or Surgical Aortic Valve Replacement (From the PARTNER 3 Trial). (2021) (5)
Percutaneous transmyocardial laser revascularization: overview of US clinical trials. (2000) (5)
Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center (2020) (5)
TCT-117 The Burden of Restenosis after Coronary Stent Implantation in the United States: Temporal Trends, Clinical Presentation, Treatment Strategies, and In-Hospital Outcomes (2018) (5)
RACE AND SEX-BASED DISPARITIES PERSIST IN THE TREATMENT OF PATIENTS WITH SEVERE, SYMPTOMATIC AORTIC VALVE STENOSIS (2019) (5)
Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes. (2021) (5)
Clinical Perspective--Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory Reform. (2016) (5)
Long‐term (5‐year) clinical evaluation of the Resolute zotarolimus‐eluting coronary stent: The RESOLUTE US clinical trial (2020) (5)
Outcomes after Transcatheter and Surgical Aortic Valve Replacement in Intermediate Risk Patients with Preoperative Mitral Regurgitation: Analysis of PARTNER II Randomized Cohort (2018) (5)
Mechanisms and Results of Additional Stent Implantation to Treat Focal In-stent Restenosis (1998) (5)
Effect of propranolol and verapamil on left ventricular diastolic filling in patients with coronary artery disease (1980) (5)
Lesion‐to‐lesion relationship of the restenosis process after placement of coronary stents (2000) (5)
Local application of antisense for prevention of restenosis. (2005) (5)
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial (2022) (5)
Reshaping bicuspid aortic valve stenosis with an hourglass‐shaped balloon for transcatheter aortic valve replacement: A pilot study (2020) (5)
THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES (2012) (5)
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model. (2018) (5)
Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial. (2021) (5)
Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry). (2011) (5)
Detection of myocardial viability in the catheterization laboratory using the Biosense-guided electromechanical mapping system. (1999) (5)
The effects of sirolimus-eluting stents on in-stent and peri-stent restenosis: An angiographic subanalysis from the SIRIUS trial (2003) (5)
Single‐dose intramuscular administration of sustained‐release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in‐stent restenosis model (1997) (5)
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. (2007) (5)
The Vulnerable Atherosclerotic Plaque (2006) (5)
Fluoroscopy-free navigation of Guided–Stent using Medical Positioning System and 3D Guided–IVUS (GIVUS™) image (2005) (5)
Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. (2020) (5)
First Transfemoral Implantation of a Novel Transcatheter Valve in an LVAD Patient With Aortic Insufficiency (2021) (5)
Balloons PTCA Is Equivalent to Stents in Patients With Small Coronaries; A Comparative Retrospective Matching Study (1998) (5)
710-6 Economic Impact of Reduced Anticoagulation After Saphenous Vein Graft Stent Placement (1995) (5)
Left main percutaneous coronary intervention crossing the threshold: time for a guidelines revision! (2009) (5)
ANALYSIS OF THE INITIAL UNITED STATES EXPERIENCE WITH THE BIOTRACE TEMPO TEMPORARY PACING LEAD IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AND OTHER CARDIAC PROCEDURES (2018) (5)
THE IMPACT OF SIX–MINUTE WALK TEST PERFORMANCE ON OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (5)
A Transcatheter Intracardiac Shunt Device for Heart Failure with Preserved Ejection Faction (2016) (5)
Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial. (2010) (5)
TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial. (2016) (5)
TCT-118 A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk Patients (2013) (5)
Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study. (2020) (5)
Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three‐dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve (2017) (5)
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (5)
730-2 Acute Angiographic, Intravascular Ultrasound and Clinical Results of Directional Atherectomy in the Optimal Atherectomy Restenosis Study (1995) (5)
Sex-Based Differences in Outcomes With Percutaneous Transcatheter Repair of Mitral Regurgitation With the MitraClip System: Transcatheter Valve Therapy Registry From 2011 to 2017. (2021) (5)
Late quantitative angiographic results after NIR stent use: results from the NIRVANA randomized trial end registries (1998) (5)
710-5 Progressive Deterioration in Late (2-Year) Clinical Outcomes After Stent Implantation in Saphenous Vein Grafts: The Multicenter JJIS Experience (1995) (5)
Outcomes of the Tryton‐dedicated bifurcation stent for the treatment of true coronary bifurcations: Individual‐patient‐data pooled analysis (2018) (5)
Intracoronary radiation to treat in‐stent restenosis in six cardiac transplant patients (2003) (5)
Impact of Frailty and Prefrailty on Outcomes of Transcatheter or Surgical Aortic Valve Replacement. (2022) (5)
SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT IN MITRAL ANNULAR CALCIFICATION- A SYSTEMATIC REVIEW (2020) (5)
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial. (2022) (4)
Prolonged intravenous urokinase infusion: an alternative pharmacologic approach in the treatment of thrombus-containing saphenous vein graft stenoses. (1992) (4)
Left Ventricular Electromechanical Mapping of Myocardial Ischemia (1999) (4)
Commissural Alignment After Transfemoral Transcatheter Aortic Valve Replacement With the JenaValve Trilogy System. (2021) (4)
Drug-eluting stents: costs vs. clinical benefit ☆ (2003) (4)
The Next Revolution: Percutaneous Aortic Valve Replacement (2010) (4)
Coronary stenting in the elderly: early in-hospital and long-term clinical outcomes (1998) (4)
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions (2022) (4)
Fate of lesion-related side branches following coronary artery stenting (1991) (4)
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective. (1998) (4)
Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions. (2004) (4)
Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 Trials. (2021) (4)
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review. (2022) (4)
Influence of Class I interferons on performance of vascular cells on stent material in vitro. (2002) (4)
Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation. (2022) (4)
FIVE YEAR CLINICAL RESULTS FROM ENDEAVOR III: A RANDOMIZED COMPARISON OF THE ZOTAROLIMUS-ELUTING VERSUS SIROLIMUS-ELUTING STENTS IN DE NOVO NATIVE CORONARY LESIONS (2010) (4)
Intravascular ultrasound imaging: in vivo peripheral and coronary artery studies. (1991) (4)
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting. (2006) (4)
Magnetic positioning system in coronary angiography and percutaneous intervention (2013) (4)
Stenting of Unprotected Left Main Coronary Artery Stenosis without Anticogulation: Immediate and Late Outcomes (1997) (4)
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age. (2003) (4)
INCIDENCE, PREDICTORS AND IMPACT OF BLEEDING EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT (SAVR): INSIGHTS FROM THE PARTNER TRIAL (2012) (4)
The Medical Device Innovation Consortium and Its Goal to Further the Efficiency of Early Feasibility Studies in the United States (2019) (4)
Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes (2018) (4)
Interpreting National Trends in Aortic Valve Replacement: Let the Buyer Beware. (2018) (4)
Does lesion length affect late outcome of patients with in-stent restenosis? Results of the multicenter laser angioplasty for stent restenosis (LARS) registry (1998) (4)
What causes focal restenosis at the margins of Palmaz-Schatz stents? A serial intravascular ultrasound study (1996) (4)
TCT-51 IVUS Predictors of Stent Expansion in Severely Calcified Lesions (2019) (4)
Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial. (2019) (4)
Echolucent neointimal hyperplasia “dark wall” after sirolimus eluting stent implantation (2004) (4)
730-5 Why Do Aorto-Ostial Lesions Behave Differently than Non-ostial Lesions? Histologic Findings in Directional Atherectomy Specimens of Aorto-Ostial vs. Non-ostial Lesions (1995) (4)
Cardiac pacing by shock waves during pulsed laser angioplasty (1990) (4)
Should sirolimus-eluting stents be the new standard for left anterior descending theraphy? A SIRIUS substudy (2003) (4)
951-74 Mechanisms of Balloon Angioplasty of In-Stent Restenosis: An Intravascular Ultrasound Study (1995) (4)
Late incomplete stent apposition following sirolimus-eluting stent: Serial quantitative intravascular ultrasound analysis from the SIRIUS trial (2003) (4)
PROVIDER-LEVEL VARIABILITY IN THE TREATMENT OF PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS (2019) (4)
Novel method for extraction of a massive refractory coronary thrombus after stent implantation (2005) (4)
Left ventricular global longitudinal strain in patients with moderate aortic stenosis. (2022) (4)
Have the outcomes of rescue angioplasty after failed thrombolytic therapy in acute myocardial infarction improved in the stent era (2002) (4)
Transcatheter Tricuspid Valve Intervention in Patients with Previous Left Valve Surgery. (2021) (4)
TCT-32 Clinical Outcomes of Imaging- and Physiology-Guided PCI Without Contrast Administration in Advanced Renal Failure (2019) (4)
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials (2021) (4)
Transesophageal echocardiographic detection of transseptal catheter-related thrombi in patients with mitral stenosis (1991) (4)
Single Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials (2021) (4)
Prevalence and Prognostic Implications of Discordant Grading and Flow-Gradient Patterns in Moderate Aortic Stenosis. (2022) (4)
Direct myocardial revascularization in ischemic heart disease. (1998) (4)
TCT-706 A Collaborative Meta-analysis of the Impact of Mitral Regurgitation on Outcomes after Transcatheter Aortic Valve Replacement: 8 Studies involving 8919 patients (2014) (4)
Major complications associated with intracoronary delivery with the palmaz-schatz stent (1991) (4)
Angiography-Derived Fractional Flow Reserve Versus Invasive Nonhyperemic Pressure Ratios. (2019) (4)
3 Preliminary results of gamma-I trial, multi institution double blind prospective randomized study evaluating the efficacy of IR-192 to reduce coronary in-stent restenosis (1999) (4)
Coronary Artery Stents (1999) (4)
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement. (2021) (4)
Angiogenesis in response to minimal laser injury in porcine myocardium (1998) (4)
Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics (2021) (4)
Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J‐TVT (2022) (4)
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. (2023) (4)
Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation (2021) (3)
The “Eyeball Test” for Risk Assessment in Aortic Stenosis: Characterizing Subjective Frailty Using Objective Measures (2018) (3)
TCT-306 Transcatheter Aortic Valve Replacement with Extremely Large Annuli Greater Than 683 mm2 Using Edwards Sapien 3 Valve – A Multicenter Experience (2017) (3)
Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve Interventions (2021) (3)
909-23 Increased Plaque Burden Affects Procedural Outcomes in Total Occlusions: An Intravascular Ultrasound Study (1995) (3)
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. (2010) (3)
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement (2021) (3)
Transcatheter Left Atrial Appendage Closure Using Preprocedural Computed Tomography and Intraprocedural 4-Dimensional Intracardiac Echocardiography. (2021) (3)
TCT-405 SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations (2014) (3)
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings assessments of the past and standards for the future. (2010) (3)
Small proximal vessels are not always small: an intravascular ultrasound study (2002) (3)
Angiographic in-stent restenosis patten predicts outcome after gamma vascular brachytherapy (2003) (3)
The radiance P-32 RDX balloon in saphenous vein grafts: A comparison of De-Novo and In-Stent restenotic lesions in the SVG brite trial (2003) (3)
Coronary Lesions: A Pragmatic Approach (2001) (3)
Efficacious and safe transluminal extraction atherectomy in patients with unfavorable coronary lesions (1991) (3)
Transcatheter valve repair for mitral insufficiency – annuloplasty (2007) (3)
Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients. (2020) (3)
Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery (2019) (3)
Prolonged antiplatelet therapy and reduced stenting eliminates late thrombosis after radiation: the SCRIPPS III trial (2002) (3)
Contribution of early lumen loss after balloon angioplasty for in‐stent restenosis to lumen loss at follow‐up (2004) (3)
TCT-701 A Multidisciplinary, Multimodality, but Minimalist (3M) approach to transfemoral transcatheter aortic valve replacement facilitates safe next day discharge home in high risk patients: 1 year follow up (2014) (3)
Images in cardiology: A saphenous vein graft aneurysm fistula causing pulmonary artery dissection. (2004) (3)
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. (2021) (3)
Results of a dose-ranging diagnostic trial of magnetic resonance angiography with MS-325, a blood pool contrast agent, for the detection of vascular occlusive disease in the aortoiliac region (2002) (3)
A RANDOMIZED COMPARISON OF VASCULAR COMPLICATIONS AFTER TAVR COMPARING THE SAPIEN VERSUS THE LOWER-PROFILE SAPIEN-XT SYSTEM IN ‘INOPERABLE’ AORTIC STENOSIS PATIENTS: A PARTNER 2 SUBSTUDY ANALYSIS (2014) (3)
Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions (2006) (3)
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. (2013) (3)
The clinical impact of sidebranch occlusion and sidebranch narrowing after elective coronary stent placement in STARS (1998) (3)
Human immunodeficiency virus infection and high c-reactive protein correlates with increased in-stent restenosis rate (2003) (3)
Acute gain and late loss relationship after coronary angioplasty correlates with geometric remodeling but not with changes in plaque volume (1996) (3)
902-3 The Impact of Intravascular Ultrasound (IVUS) on Post-Stent Deployment Balloon Dilatation Strategies (1995) (3)
A REVIEW OF DRUG-ELUTING STENTS: WHY ALL THE EXCITEMENT? (2003) (3)
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". (2015) (3)
Summary: international consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (3)
Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study (2022) (3)
Minimally Invasive versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-risk Patients. (2021) (3)
Three‐year survival of transcatheter versus surgical aortic valve replacement in dialysis (2022) (3)
Long‐Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End‐Stage Renal Disease (2021) (3)
The Heparin Infusion Prior to Stenting (HIPS) Trial: Procedural, In-hospital, 30 Day, and six Month Clinical, Angiographic and IVUS Results (1998) (3)
Fluorescence-guided laser angioplasty: Updated clinical results and future directions (1990) (3)
TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial. (2016) (3)
720-3 Predictors for Adverse Clinical Events are Different in Stents and PTCA: Results from the STent REStenosis Study (1995) (3)
Aortic Valve Disease and TreatmentTCT-747 Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial (2013) (3)
Insights into the mechanism of restenosis after PTCA and stenting. (1998) (3)
Abstract 2518: Clinical and Angiographic Outcomes after Percutaneous Revascularization of Chronic Total Occlusions with Bare-Metal and Drug-Eluting Stents: 3-year Follow-up Results from an International Multicenter CTO Registry (2008) (3)
Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review. (2020) (3)
P567Pulmonary artery denervation for the treatment of pulmonary arterial hypertension: preliminary results of the TROPHY 1 Study (2018) (3)
Morphological Patterns of In-Stent Chronic Total Occlusions: An Intravascular Ultrasound Study. (2018) (3)
Counterpoint: Access to transcatheter aortic valve replacement should not be limited to high-volume surgical centers. (2013) (3)
CLINICAL RESEARCH Interventional Cardiology Late Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation A Serial Intravascular Ultrasound Analysis (2005) (3)
State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. (2018) (3)
Stent implantation in aortocoronary vein grafts: A multicenter registry report (1991) (3)
Gamma II, a prospective multicenter registry, with fixed dosing regimen compared to the gamma I trial, using IR-192 in the treatment of coronary treatment of coronary in-stent restenosis (2000) (3)
INCIDENCE OF VASCULAR COMPLICATIONS IN TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT ACCORDING TO FEMORAL ARTERY ACCESS TECHNIQUE (2014) (3)
Correlates and Impact of Coronary Artery Calci ﬁ cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (3)
Do overlapping multiple sirolimus-eluting stents impact angiographic and clinical outcomes? Insights from the SIRIUS trial (2003) (3)
Renal denervation for the treatment of hypertension: Making a new start, getting it right (2015) (3)
A meta-analysis on the clinical and angiographic outcomes of stents vs PTCA in the different coronary vessels in the benestent-1 and stress 1 and 2 trials (1996) (3)
From Prototype to Regulatory Approval (2004) (3)
Changing the Conversation to TAVR First!: Aftermath of the Low-Surgical Risk TAVR Studies. (2019) (3)
Interventional cardiology: Hand me your radial artery to protect your kidney (2010) (3)
Multichannel balloon catheter. (1996) (2)
Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve‐in‐Valve Registry (2020) (2)
Myocardial Contractile Mechanics in Ischemic Mitral Regurgitation: Multicenter Data Using Stress Perfusion Cardiovascular Magnetic Resonance. (2022) (2)
Acute Cardiac Care: Apocalypse Now! (2006) (2)
Intracoronary Ultrasound for Optimizing Stent Implantation (2010) (2)
934-27 Patterns of Target Lesion Calcification in Coronary Artery Disease (1995) (2)
Transthoracic access for transcatheter aortic valve replacement: technique using the Edwards Sapien Retroflex delivery system. (2014) (2)
Angiographic outcomes after arterial recanalization of refractory occlusions with the PRIMA™ excimer laser wire (1996) (2)
30 DAY OUTCOMES FROM THE PARTNER II TRIAL FOR TRANSAPICAL AND TRANSFEMORAL 29MM TAVR IN INOPERABLE PATIENTS WITH THE EDWARDS SAPIEN XT (2014) (2)
Abstract 2536: Impact Of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus-eluting and Bare Metal Stent Implantation: Results from the Sirius Trials (2008) (2)
THE ROLE OF PRIOR BALLOON AORTIC VALVULOPLASTY IN PATIENTS UNDERGOING TAVR: A PARTNER I SUBSTUDY ANALYSIS (2014) (2)
Novel Drug Eluting Stent Systems (2011) (2)
Initial Report of Gamma Radiotherapy for Diffuse Coronary Restenosis: The SCRIPPSII Trials (1998) (2)
Transcatheter Aortic Valve Replacement for Patients at Low Surgical Risk-Selective or Ubiquitous? (2019) (2)
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. (2016) (2)
ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS UNDERGOING TAVR: INSIGHTS FROM THE PARTNER TRIAL (2014) (2)
Role of intravascular ultrasound and Doppler flow studies in coronary interventions. (1998) (2)
Surgical Applications Of Heavy Metal Fluoride Glass Fibers (1988) (2)
951-75 Comparative Analysis of Long Term Clinical Outcomes After Native Coronary versus Saphenous Vein Graft Stent Implantation (1995) (2)
EARLY AORTIC VALVE REPLACEMENT VERSUS A CONSERVATIVE STRATEGY FOR ASYMPTOMATIC SEVERE AORTIC STENOSIS: META-ANALYSIS OF OBSERVATIONAL STUDIES (2016) (2)
Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment (2017) (2)
The quickening path ahead for renal denervation therapies? (2014) (2)
Health Services and Outcomes Research Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis (2012) (2)
Immediate effect of Biosense guided percutaneous direct myocardial revascularization with holmium:yttrium aluminium garnet laser on myocardial contractility assessed by transesophageal echocardiography (2000) (2)
Intravascular ultrasound of atherosclerotic vessels: changes observed during interventional procedures. (1994) (2)
Predictors of clinical and angiographic restenosis in the Sirolimus-Eluting Bx VELOCITY stent trial (2003) (2)
Detection of peripheral arterial disease in patients presenting for coronary angiography and/or intervention patients study (PIPS) (2003) (2)
Routine High Pressure Post-stent Dilatation did Not Influence Clinical Restenosis in STARS (1998) (2)
1018-50 Procedural Results and Long Term Clinical Outcomes in Aorto-Ostial Saphenous Vein Graft Lesions After New Device Angioplasty (1995) (2)
Abstract 16392: Oxido-Reductive Regulation of Human Vascular Remodeling by the Orphan Receptor Tyrosine Kinase Ros1 (2014) (2)
Time course of geometric remodeling after coronary angioplasty: Balloon angioplasty versus directional coronary atherectomy (1996) (2)
Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention. (2019) (2)
1044-54 Influence of vessel wall calcium on neointimal growth following bare metal and sirolimus-eluting stent implantation: A 3-D intravascular ultrasound substudy of the SIRIUS trial (2004) (2)
Pulmonary Embolism Response Team utilization during the COVID-19 pandemic (2021) (2)
Images in cardiovascular medicine. Left ventricular electromechanical mapping of myocardial ischemia. (1999) (2)
Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents (2)
Bleeding Outcomes in Patients Undergoing Combined Percutaneous Coronary Interventions+Transcatheter Aortic Valve Replacement: Time for an Adjustment to the CathPCI Bleeding Model? (2020) (2)
TCT-30 Ultra-Low Contrast Coronary Angiography in Patients With Advanced Chronic Kidney Disease: Feasibility and Outcomes Compared With Conventional Angiography (2019) (2)
First International New Intravascular Rigid-Flex Endovascular Stent Study (FINESS): Clinical and Angiographic Results After Elective and Urgent Stent Implantation fn1fn1This study was supported in part by a grant from Medinol, Ltd., Kiryat Atidim, Tel Aviv, Israel. (1997) (2)
TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial (2018) (2)
SEX-BASED DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER REPAIR OF MITRAL REGURGITATION WITH THE MITRALCLIP SYSTEM (2019) (2)
Abstract 23085: 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Bioprostheses (Mitral Valve-in-Valve): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves) (2017) (2)
Treatment of calciﬁed coronary lesions with Palmaz–Schatz stents An intravascular ultrasound study (2)
Paclitaxel-coated stent: is there a light at the end of the tunnel? (2001) (2)
THE IMPORTANCE OF VASCULAR COMPLICATIONS AFTER TRANS-FEMORAL TRANS-CATHETER AORTIC VALVE REPLACEMENT (TAVR): INSIGHTS FROM THE PARTNER TRIAL (2012) (2)
Intravascular ultrasound of saphenous vein grafts after PTCA and investigational angioplasty procedures (1991) (2)
THE ASSOCIATION OF FRAILTY WITH MORTALITY IN HIGH RISK PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS OF THE PARTNER II ALTERNATIVE ACCESS COHORTS (2016) (2)
Intravascular-ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy: impact on long-term clinical follow-up (2001) (2)
Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial (2018) (2)
Catheter-based electromechanical mapping to assess myocardial viability: a comparative analysis with SPECT radionuclide perfusion imaging (2002) (2)
TCT-686 Impact of Left Ventricular Remodeling on Clinical Outcomes after TAVR: Insights from the PARTNER I Trial (2014) (2)
Prognostic value of left ventricular ejection fraction and symptom severity in patients with moderate aortic stenosis (2021) (2)
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy (2022) (2)
Transcatheter valve-in-valve implantation for early prosthetic valve degeneration in aortic and mitral positions. (2014) (2)
Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries (2022) (2)
Gender differences in device selection and procedural outcome: a national cardiovascular network (NCN) report (1998) (2)
Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials. (2022) (2)
Treatment of long lesions in small tortuous coronary vessels with a new intravascular rigid-flex (NIR) stent (1996) (2)
Cooperation, innovation and transition: the new focus of the China Interventional Therapeutics (CIT) congress. (2013) (2)
Should patients wtih discrete, de novo coronary stenoses undergo stenting as a primary procedure? risk vs. Beneftt (1991) (2)
Endpoints for tricuspid regurgitation trans-catheter therapy trials. (2019) (2)
Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement (2020) (2)
Incidence and Severity of Paravalvular Aortic Regurgitation With Multidetector Computed Tomography Nominal Area Oversizing or Undersizing After Transcatheter Heart Valve Replacement With the Sapien 3 A (2017) (2)
RADIATION EXPOSURE DURING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PROCEDURES (2011) (2)
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type. (2022) (2)
TCT-543 Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study (2012) (2)
CLINICAL IMPACT OF NEW LEFT BUNDLE BRANCH BLOCK IN INTERMEDIATE RISK PATIENTS UNDERGOING TAVR: AN ANALYSIS OF THE PARTNER II TRIAL AND REGISTRIES (2018) (2)
TCT-94 Outcomes Of Patients With Severe Aortic Stenosis And Chronic Obstructive Pulmonary Disease Treated With Transcatheter Versus Surgical Aortic Valve Replacement Versus Medical Therapy (2012) (2)
TCT-114 Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) (2013) (2)
Impact of diabetes on coronary remodeling in patients with acute coronary syndromes: An intravascular ultrasound study (2003) (2)
First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement. (2023) (2)
Response to Letter Regarding Article, "Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy". (2015) (2)
IMPACT OF PREOPERATIVE MODERATE/SEVERE MITRAL REGURGITATION ON PATIENTS UNDERGOING PERCUTANEOUS AND SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (2)
Relationship between late loss, diameter stenosis and target lesion revascularization after stent implantation: An examination of surrogate endpoints from a pooled analysis of eight large randomized DES trials (2006) (2)
Coronary atherectomy: a clinical update (1990) (2)
Transcatheter versus Surgical Aortic Valve Replacement in Patients with Moderate to Severe Chronic Kidney Disease: A Systematic Review and Analysis (2018) (2)
COSTS OF PERIPROCEDURAL COMPLICATIONS IN PATIENTS TREATED WITH TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER TRIAL (2014) (2)
Favorable effect of γ‐radiation for in‐stent restenosis: Effect of diabetes on angiographic and clinical outcomes (2004) (2)
Abstract 23079: Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Mitral Valve-in-Valve) and Surgical Rings (Mitral Valve-in-Ring) in the United States: Data From the STS/ACC/TVT Registry (2017) (2)
Distribution of tissue growth in Palmaz-Schatz stents: Insights from a serial intravascular ultrasound study (1996) (2)
Effects of verapamil alone and combined with propranolol on left ventricular systolic function in patients with coronary artery disease (1980) (2)
First use of a novel cobalt chromium coronary stent in humans: Clinical and angiographic outcomes (2003) (2)
TCT-756 Incidence, Predictors, and Prognostic Impact of Late Bleeding (≥30 days) Complications after Transcatheter Aortic Valve Replacement (TAVR) (2014) (2)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization (2016) (2)
Gamma radiation for in‐stent restenosis: effect of lesion length on angiographic and clinical outcomes (2004) (2)
Procedural and Long-Term Clinical Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions in Women: A Report From the Multinational Cto Registry (2011) (2)
Advantages of the 2.94-μm wavelength for medical laser applications (1986) (2)
Validation and feasibility of in vivo intravascular ultrasound imaging with a new flexible catheter (1989) (2)
Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality. (2022) (2)
LONG-TERM OUTCOMES AFTER REVASCULARIZATION FOR STABLE ISCHEMIC HEART DISEASE: AN INDIVIDUAL PATIENT-LEVEL POOLED ANALYSIS OF 19 RANDOMIZED CORONARY STENT TRIALS (2020) (2)
Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent Trial. (2003) (2)
720-1 Incidence of and Factors Associated with Abrupt Closure in Patients Undergoing Elective, New Device Angioplasty in Native Coronary Arteries (1995) (2)
A RANDOMIZED COMPARISON OF THE ENDEAVOR DRUG (ABT-578) ELUTING STENT VERSUS TAXUS PACLITAXEL-ELUTING STENT IN DIABETIC PATIENTS: THREE-YEAR OUTCOMES FROM ENDEAVOR IV (2010) (2)
SERIAL INTRAVASCULAR ULTRASOUND EVIDENCE FOR ARTERIAL REMODELING AS A MECHANISM OF RESTENOSIS FOLLOWING INTERVENTIONAL CORONARY PROCEDURES (1997) (2)
Impact of Predilation During Transcatheter Aortic Valve Replacement (2021) (2)
Plasma Verapamil Levels in Patients with Hypertrophic Cardiomyopathy: Interpatient Variability and Clinical Usefulness (1982) (2)
Impact of paravalvular leak following transcatheter aortic valve replacement on one-year mortality: analysis of the combined PARTNER cohorts (2013) (2)
Restenosis following percutaneous coronary interventions: a clinicalproblem (2005) (2)
Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes. (2022) (2)
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes From the BIONICS and NIREUS Trials. (2020) (2)
A saphenous vein graft aneurysm fistula causing pulmonary atery dissection (2004) (2)
ACUTE KIDNEY INJURY FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH AN INCREASED RISK OF CHRONIC KIDNEY DISEASE AT 1 YEAR (2014) (1)
Impact of Short-Term Complications on Mortality and Quality of Life after TAVR (2019) (1)
Different mechanism of lumen enlargement during balloon angioplasty between focal and diffuse in-stent restenosis (2002) (1)
TCT-254 Very Low Intravenous Contrast Dose (20cc) Protocol for Computed Tomography Angiography (CTA) Providing Comprehensive Cardiac and Vascular Assessment for Transcatheter Aortic Valve Replacement (TAVR) in Patients with Chronic Kidney Disease (CKD) (2014) (1)
Abstract 2642: Impact of Late Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation on 3-Year Clinical Events. Intravascular Ultrasound Analysis from the Multicenter, Randomized, RAVEL, E-SIRIUS and SIRIUS Trials (2006) (1)
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials. (2023) (1)
In‐hospital outcomes after transcatheter edge‐to‐edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010–2016 National inpatient sample (2021) (1)
Abstract 19840: Transcatheter Left Gastric Artery Therapy for Treating Obesity (2015) (1)
P4666Higher BNP levels after transcatheter aortic valve implantation are associated with increased mortality and hospitalizations (2019) (1)
[Stent coated with bovine pericardium: in vitro evaluation, in animals, and initial results in humans]. (2001) (1)
LONG-TERM CLINICAL IMPACT OF CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY FOLLOWING PCI AN ADAPT-DES SUB-STUDY (2021) (1)
A modified directional atherectomy catheter for resection of calcified atherosclerotic plaques (1995) (1)
TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter (2012) (1)
TCT-418 Confirmation of the Prognostic Capability of the SYNTAX Score-II Among 1,528 Patients who Underwent Left Main PCI (2013) (1)
918-22 Effect of Non-target Lesion Events on the Predictive Value of 6-Month Angiography for Late (12 Month) Clinical Outcome After PTCA (1995) (1)
EFFECTIVE ORIFICE AREA REFERENCE VALUES WITH THE DIFFERENT SIZES OF THE SAPIEN 3 BALLOON-EXPANDING TRANSCATHETER AORTIC VALVE (2016) (1)
Percutaneous Valve Insertion for the Treatment of Calcific Aortic Valve Stenosis (2005) (1)
The Fiber of Modern Society (2011) (1)
Qualitative assessment of coronary lesions treated with sirolimus-eluting stents: Serial intravascular ultrasound analysis from the SIRIUS trial (2003) (1)
Outcomes of Retrograde Approach for Chronic Total Occlusions by Guidewire Location. (2021) (1)
SEX–SPECIFIC DIFFERENCES IN LATE MORTALITY AFTER TRANSCATHETER AVR IN THE PARTNER TRIAL (2013) (1)
Predictors of intimal hyperplasia accumulation within Palmaz-Schatz stents: a serial quantitative angiographic and intravascular ultrasound study (1998) (1)
Current status of percutaneous transmyocardial revascularisation. (1998) (1)
Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions InvolvingLarge Side Branches (2016) (1)
Bioprosthetic Valve Thrombosis: Insights from Transcatheter and Surgical Implants (2020) (1)
TCT CONNECT-474 Incidence and Impact of Prosthesis–Patient Mismatch after Aortic Valve Replacement in the PARTNER 2 Trial and Registry (2020) (1)
ANTITHROMBOTIC THERAPY AND CARDIOVASCULAR RISK IN PATIENTS WITH ATRIAL FIBRILLATION AT HIGH RISK FOR THROMBOEMBOLIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL (2019) (1)
TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial (2017) (1)
Oral rapamycin for the prevention of in-stent restenosis (2003) (1)
PREDICTORS OF POOR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PARTNER TRIAL (2013) (1)
Acute effects of percutaneous direct myocardial revascularization with biosense™ holmium:YAG laser system (1998) (1)
Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study (2022) (1)
2000Determinants of progression from none and mild to moderate and severe native tricuspid regurgitation: results from a large-scale echocardiographic study (2017) (1)
TCT-49 Perceived Versus Competency-Based Assessment of Interventional Cardiology Fellows’ Abilities in Intracoronary Physiology and Imaging (2019) (1)
Transcatheter aortic valve implantation: Clinical outcomes (2012) (1)
The Effects of Excimer Laser Coronary Angioplasty in Calcified Lesions : Investigation with Intravascular Ultrasound (1994) (1)
ROUTINE EARLY DISCHARGE AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A PROPENSITY SCORE ANALYSIS FROM THE PARTNER 2 SAPIEN 3 STUDY (2018) (1)
Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications. (2023) (1)
Carotid Artery Stenting in Patients with High-Risk Anatomy for Carotid Endarterectomy (2001) (1)
INTRAVASCULAR ULTRASOUND-DERIVED LEFT MAIN MINIMUM LUMEN AREA AND PLAQUE BURDEN PREDICT 12-YEAR CARDIAC MORTALITY (2021) (1)
Direct stenting improves target lesion revascularization in saphenous vein graft lesions: an intravascular ultrasound-guided study (2002) (1)
Long-Term Clinical Effects of Verapamil in Patients with Hypertrophic Cardiomyopathy* (1982) (1)
An advanced antisense (AVI-4126) for local and stent-based delivery for prevention of restenosis after PCI (current status and future developments) (2005) (1)
Assessing a strategy of initial stand-alone extractional atherectomy followed by staged stent placement in degenerated saphenous vein graft lesions. (2000) (1)
Prognostic Implications of Change in Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation. (2022) (1)
TCT-115 Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience (2013) (1)
Intravascular ultrasound predictors of late recurrence after stent implantation in small coronary arteries (2003) (1)
Abstract 1715: Necrotic Core and its Ratio to Dense Calcium are Predictors of High-risk Non-ST-Elevation Acute Coronary Syndromes: Results from the Prospective, Multi-center, Global VH-IVUS Registry (2007) (1)
Neurocognitive Function Change in Low-Risk Patients Undergoing TAVR Versus SAVR: Insights From PARTNER-3. (2020) (1)
1139-55 Optimal geometry is still important with sirolimus-eluting stents: Incomplete stent expansion as a risk for target lesion revascularization (2004) (1)
Coronary Orbital Atherectomy in Patients With Severe Aortic Stenosis. (2022) (1)
IMPACT OF LEVEL OF ANAESTHESIA USING THE VANCOUVER CLINICAL PATHWAY FOR TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE 3M TAVR STUDY (2018) (1)
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis (2021) (1)
Impact of Palmaz-Schatz stents on adjacent reference segments: A serial intravascular ultrasound study (1996) (1)
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions. (2006) (1)
IMPACT OF ACUTE KIDNEY INJURY AFTER SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (1)
TCT-50 Comparison of Saline and Radiographic Contrast for Optical Coherence Tomography-Guided Intracoronary Imaging (2019) (1)
Drug-Eluting Stents Versus Bypass Surgery for Left Main Disease: An Updated Meta-Analysis of Randomized Controlled Trials With Long-Term Follow-Up. (2020) (1)
TCT-308 Impact of Periprocedural Major Adverse Events After PCI and CABG on Long-Term Outcomes in Patients With Left Main Disease: The EXCEL Trial (2019) (1)
RESOLUTE US Clinical Trial System in the Treatment of De Novo Lesions in Native Coronary Arteries: The Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent (2011) (1)
Factors Affecting Rate of Progression of Aortic Stenosis and Its Impact on Outcomes. (2022) (1)
CONCENTRIC LEFT VENTRICULAR REMODELING IS ASSOCIATED WITH LOW-FLOW SEVERE AORTIC STENOSIS AND LESS REVERSE REMODELING AFTER TAVR: A PARTNER 2 TRIAL ANALYSIS (2017) (1)
TCT-661 The Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the PARTNER II SAPIEN 3 Cohort. (2016) (1)
TCT-68 Influence of Final Kissing Balloon Inflation on Long-Term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial (2019) (1)
Impact of vessel size after coronary vascular brachytherapy: a report of 990 patients (2002) (1)
Severe spasm of the free radial artery graft in a patient undergoing high-risk angioplasty under percutaneous cardiopulmonary support. (1999) (1)
1101-65 Predictors of edge stenosis following sirolimus-eluting stent deployment: A quantitative intravascular ultrasound analysis from the SIRIUS trial (2004) (1)
TCT-416 Impact of Diabetes Status on Long-Term (6 years) Outcomes after Percutaneous Coronary Intervention of Left Main Disease: Result from a Real World Experience of 1,528 Consecutive Patients (2013) (1)
Ambulatory blood pressure results of symplicity HTN-3 trial (2014) (1)
TCT-347 Neurologic Events in Patients Treated with Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement: Insights from the PARTNER (Placement of Aortic Transcatheter Valves) Trial (2017) (1)
DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENT TREATMENT BY GEOGRAPHIC REGION (2012) (1)
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. (2004) (1)
Trans-epicardial transplantation of mature endothelial cells induces neoangiogenesis and improves LV function in an animal model of ischemic cardiomyopathy (2002) (1)
Oral sirolimus for recalcitrant in-stent restenosis (2002) (1)
Coronary Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement. (2017) (1)
A MULTIDISCIPLINARY, MULTIMODALITY, BUT MINIMALIST (3M) APPROACH TO TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FACILITATES SAFE NEXT DAY DISCHARGE HOME IN HIGH RISK PATIENTS: 1 YEAR FOLLOW UP (2014) (1)
NEW PACEMAKER IMPLANTATION AFTER SURGICAL AORTIC VALVE REPLACEMENT IN THE PARTNER TRIALS: RATES, RISK FACTORS, AND CLINICAL OUTCOMES (2018) (1)
TCT-225 Impact of frailty on a minimalist approach and early discharge following TAVR: insights from the 3M TAVR Study (2018) (1)
TCT-83 Provisional vs. Planned Two-stent Technique in Patients with Distal Bifurcation Left Main Disease Undergoing PCI: The EXCEL Trial (2017) (1)
TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (1)
TCT-699 The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort (2014) (1)
Intravascular imaging and physiologic lesion assessment to define critical coronary stenoses. (1999) (1)
TCT CONNECT-468 Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients at Low Surgical Risk: An Analysis From the PARTNER 3 Trial (2020) (1)
percutaneous coronary intervention: Development and initial validation A simple risk score for prediction of contrast-induced nephropathy after (2009) (1)
TCT-181 Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET II Trials (2013) (1)
Percutaneous coronary intervention and discretionary atherectomy in patients with aortic stenosis: 2016-2019 National Inpatient Sample. (2023) (1)
The HEP@NET study: an internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation (2002) (1)
TCT-892 Predictors of “futility” with transcutaneous aortic valve replacement therapy (TAVR): An analysis from the PARTNER randomized trial (2012) (1)
TCT-491 Incidence of Peri-Procedural Myocardial Infarction after Bifurcation Percutaneous Coronary Intervention According to Different Definitions: Insight from the Tryton IDE randomized trial (2015) (1)
TCT-774 Circulatory Support is Associated with Higher Mortality During TAVR (2013) (1)
TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry. (2020) (1)
NATIONAL TRENDS OF PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS FROM THE STS/ACC TVT REGISTRY (2021) (1)
TCT-706 Cardiovascular and Non-Cardiovascular Death After PCI: Insights From 32,882 Patients Enrolled in 21 Randomized Trials (2018) (1)
CRT-70 The Resolute Zotarolimus-eluting Stent Is Equally Safe And Effective In Women And Men With Coronary Artery Disease: Two-year Outcomes From The Pooled Resolute Clinical Program (2013) (1)
CORONARY Impact of the Complexity of Bifurcation Lesions Treated With Drug-Eluting Stents The DEFINITION Study ( De fi nitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts ) (2014) (1)
TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study (2019) (1)
Stent implantation in saphenous vein grafts. (1994) (1)
Coronary atherectomy devices (1994) (1)
Pericoronary Adipose Tissue Attenuation in Patients With Acute Coronary Syndrome Versus Stable Coronary Artery Disease (2023) (1)
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions. (2022) (1)
POOR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: ASSOCIATIONS OF MORTALITY AND QUALITY OF LIFE WITH FRAILTY IN THE PARTNER TRIAL (2015) (1)
TCT-42 Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: An Analysis of the PARTNER 3 Trial (2021) (1)
PREDICTORS OF WORSENING OR PERSISTENT TRICUSPID REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (1)
Overlapping sirolimus-eluting stents: Intravascular ultrasound analysis frok the SIRIUS trial (2003) (1)
Evolution of definitions and understanding of vascular complications related to transcatheter aortic valve replacement. (2013) (1)
TCT-86 Which patients are undergoing transcatheter tricuspid repair today? An update from the International Multicenter Transcatheter Tricuspid Valve Therapies (TriValve) Registry (2017) (1)
1006-56 Virtual histology of intravascular ultrasound images: Feasibility and clinical correlations in humans (2004) (1)
TCT CONNECT-497 Incidence and Predictors of Cardiogenic Shock Following Tricuspid Valve Repair or Replacement (2020) (1)
Elective GR II stenting in small vessels: multicenter results (1998) (1)
The Palmaz-SchatzTM stent (1993) (1)
TCT-95 The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement: A Report from the PARTNER I Trial (2015) (1)
Histologic responses during in-stent neointimal regression in a porcine coronary model (1998) (1)
ECG-Independent Calculation of Instantaneous Wave-Free Ratio (2017) (1)
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. (2019) (1)
Starting small but aiming high: important lessons in establishing a successful TAVR program. (2014) (1)
775-3 Altered Vascular Biomechanical Properties Precede Angiographically Detectable Disease in Early Atherosclerosis of LDL Receptor Deficiency (1995) (1)
TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (1)
Heart Team 2.0. (2019) (1)
TCT-113 Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial (2013) (1)
TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data (2021) (1)
Rat model of veno-arterial extracorporeal membrane oxygenation (2014) (1)
DIFFERENT PATTERNS OF CHRONIC TOTAL OCCLUSIONS IN THE RIGHT AND LEFT CORONARY ARTERIES: AN INTRAVASCULAR ULTRASOUND STUDY (2012) (1)
USEFULNESS OF ATHEROSCLEROTIC PLAQUE DIFFUSENESS AND VOLUME BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR PREDICTING CORONARY LESION-SPECIFIC ISCHEMIA BY FRACTIONAL FLOW RESERVE (2016) (1)
TCT-839 Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis is More Likely to Improve than Worsen CKD Stage: Analysis of the PARTNER 1, 2A, and S3 Trials (2018) (1)
P676Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: a pilot study (2018) (1)
Abstract 4452: What are the Reasons for Clopidogrel Discontinuation after PCI? (2008) (1)
2228 Intracoronary radiation: Results of scripps I, a randomized clinical trial (1999) (1)
USEFULNESS OF INTRAVASCULAR ULTRASOUND FOR DETECTING ATHEROSCLEROSIS PROGRESSION OR REGRESSION. (1997) (1)
ASSESSMENT OF BALLOON-EXPANDABLE TRANSCATHETER HEART VALVE OVERSIZING USING THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY SEMI-AUTOMATION VERSUS. DIRECT PLANIMETRY: ALL METHODS ARE NOT CREATED EQUAL (2016) (1)
LONG-TERM OUTCOMES IN ASYMPTOMATIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS FOR STABLE CORONARY ARTERY DISEASE: ANALYSIS FROM A LARGE POOLED RANDOMIZED TRIAL DATASET (2019) (1)
Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER‐2 (2022) (1)
Reasons for lesion uncrossability as assessed by intravascular ultrasound (2022) (1)
TCT-614 The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database (2018) (1)
Tissue effects of pulsed infrared lasers: Implications for laser angioplasty (1991) (1)
CHARACTERIZING AND QUANTIFYING MITRAL ANNULAR CALCIFICATION FOR PATIENT-PREDICTIVE MODELING IN THE ERA OF TMVR (2020) (1)
Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (1)
Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
Molecular Pathophysiology of Cardiac Injury and Cardiac Microthrombi in Fatal COVID-19: Insights from Clinico-histopathologic and Single Nuclei RNA Sequencing Analyses (2021) (1)
TCT-112 Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach (2013) (1)
Gender differences in clinical outcomes after percutaneous coronary intervention in small coronary arteries (2002) (1)
Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial". (2020) (1)
TCT-95 Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial (2012) (1)
TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis. (2016) (1)
Relation between Modified Body Mass Index and Adverse Outcomes after Aortic Valve Implantation. (2021) (1)
Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention (2022) (1)
822-3 Sirolimus-Eluting Stents for Failed Brachytherapy: Results From the SECURE Registry (2004) (1)
In-Hospital Outcomes of Tricuspid Transcatheter Tricuspid Valve Repair: An Analysis From the National Inpatient Sample (2022) (1)
1-Year Outcomes of Transcatheter Tricuspid Valve Repair. (2023) (1)
Intimal hyperplasia thickness is independent of stent size: a serial intravescular ultrasound study (1998) (1)
TCT CONNECT-92 Initial Single-Center Experience With Transfemoral Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Regurgitation (2020) (1)
Reply: Is There a Link Between Stroke, Anticoagulation, and Platelet Reactivity? The Multifactorial Stroke Mechanism Following TAVR. (2019) (1)
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. (2021) (1)
LATE-TERM SAFETY AND EFFICACY OUTCOMES FOLLOWING TREATMENT WITH ZOTAROLIMUS-ELUTING STENTS: 5-YEAR RESULTS OF THE POOLED ENDEAVOR TRIALS PROGRAM (2010) (1)
Comprar Stilbenes: Applications in Chemistry, Life Sciences and Materials Science | Renu Virmani | 9783527323883 | Wiley (2009) (1)
Clinical and Functional Outcomes Associated With Myocardial Injury After€Transfemoral and Transapical Transcatheter Aortic Valve Replacement (1)
IMPROVEMENTS IN PHYSICAL ACTIVITY LAG BEHIND IMPROVEMENT IN FUNCTIONAL CAPACITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN OLDER ADULTS (2012) (1)
Introduction: Interventional Cardiology: A Vision for the 21st Century (1996) (1)
Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement. (2020) (1)
TRANSCATHETER AORTIC VALVE REPLACEMENT FOR FAILED SURGICAL BIOPROSTHESES. EARLY RESULTS FROM THE PARTNER II VALVE-IN-VALVE REGISTRY (2014) (1)
Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black Adults (2022) (1)
710-3 Stent Placement is Safe and Effective in the Treatment of Older (>4 Years) Saphenous Vein Graft Lesions (1995) (1)
Intracoronary gamma radiation for elderly patients (2003) (1)
[Recent trend in interventional cardiology--drug-containing stents]. (2003) (1)
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction. (2023) (1)
Is Depression an Important New Mortality Risk Factor After Aortic Valve Replacement or Simply a Component of the Geriatric Disease Spectrum? (2018) (0)
TCT-104 One-Year Clinical Outcomes Following Open Transatrial Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification (2021) (0)
Primary stent deployment for obstructive lesions of the subclavian or innominate artery (1998) (0)
Impact of lesion length on vascular brachytherapy failure: a comparison of beta (b) versus gamma (g) irradiation in 990 patients (2002) (0)
Extrapulmonary manifestations of COVID-19 (2020) (0)
Abstract 18185: Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A (2013) (0)
TCT-377 Safety of Ultra-Low Contrast Coronary Angiography in Patients with Advanced Chronic Kidney Disease. (2016) (0)
Late Clinical Outcomes of Cordis Tantalum Coronary Stenting without Anticoagulation:Validation of Angiographic Measurement and In-stent Restenosis by Intravascular Ultrasound (1997) (0)
TCT-785 The "Eyeball Test" in Aortic Stenosis: Characterizing Subjective Frailty with Objective Measures (2013) (0)
TCT-489 Use of a Percutaneous Left Ventricular Assist Device for Patients with Cardiogenic Shock (2018) (0)
Comparison of early and late clinical events in coiled vs. tubular slotted stents (1998) (0)
TCT-124 Impact of level of anaesthesia using the Vancouver Clinical Pathway for transcatheter aortic valve replacement: Insights from the 3M TAVR Study (2018) (0)
Drug-Eluting Stents Costs Versus Clinical Benefit EVIEW : E XPERT (2003) (0)
Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future (2022) (0)
TCT CONNECT-396 Predictive Modeling of the Primary Outcome of a Large-Scale Randomized Trial of Quantitative Flow Ratio Versus Angiography-Guided PCI Using Data Simulation (2020) (0)
Abstract 2564: Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndromes in the Drug-Eluting Stent Era: Analysis from the ACUITY trial (2007) (0)
Relationship of the degree of procedural anticoagulation to outcomes after stent implantation (2002) (0)
Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the Placement of Aortic Transcatheter Valves Trial and Registries (2022) (0)
TCT-669 Very Low Intravenous Contrast Dose (20 cc) Computed Tomographic Angiography Protocol for Pre-Procedural Assessment of the Aortic Annulus Prior to Transcatheter Aortic Valve Replacement: Validation by 3-Dimensional Transesophageal Echocardiography (2014) (0)
TCT-615 Percutaneous Coronary Intervention for Patients with Ischemic Cardiomyopathy Is Associated with Low Mortality and Improves Ejection Fraction: A Meta-Analysis of 3,844 Patients (2018) (0)
Abstract 4487: Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: One Year Outcome (2008) (0)
In vivo spectroscopy of human coronary stenoses (1991) (0)
4.W26.5 Characterizing and quantitating early atherogenesis in rabbits and man in vivo (1997) (0)
TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials (2018) (0)
CLINICAL IMPLICATIONS OF NEW LEFT BUNDLE BRANCH BLOCK: SUB–ANALYSIS FROM THE PARTNER TRIAL (2013) (0)
A new standard of care for inoperable, severe aortic stenosis: implications of the PARTNER trial (2011) (0)
Intravascular Stent Deployment Across Vein Graft Anastomoses: Acute and Chronic Results (1992) (0)
TCT-658 The Mechanism and Pattern of In-Stent Restenosis Among Bare Metal, 1st Generation, and 2nd Generation Drug-Eluting Stents: An Intravascular Ultrasound Study (2014) (0)
Clinical Outcomes of Patients With Low Left Ventricular Ejection Fraction Undergoing Intracoronary Stenting (1998) (0)
The effect of height on vascular events after percutaneous intervention (1998) (0)
Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup. (2017) (0)
TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1. (2016) (0)
1 Durability of Long-Term Clinical Benefit of Sirolimus-Eluting Stent : Three-Year Follow-up of the SIRIUS Study(New Strategy of Coronary Intervention in DES Era,Plenary Session 1 (PL1) (IHD),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
ADDITIONAL STENT EXPANSION WITH POST-DILATATION OF BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE (2012) (0)
BLOOD PRESSURE EFFECTS OVER TIME OF BIPOLAR RADIOFREQUENCY RENAL DENERVATION IN UNTREATED HYPERTENSION (2021) (0)
Ischemia-Mediated Dysfunction in Sub-Papillary Myocardium as a Marker of Functional Mitral Regurgitation – Multicenter Data from the Society for Cardiovascular Magnetic Resonance Registry (2021) (0)
Transcatheter Left Ventricular Restoration in patients with Heart Failure. (2023) (0)
Transcatheter Aortic Valve Implantation: Review of Current Evidence (2014) (0)
TCT-138 Right Ventricular Remodeling and Clinical Outcomes Following Transcatheter Tricuspid Valve Intervention (2021) (0)
Impact of smoking habit on clinical outcomes after percutaneous coronary intervention (2002) (0)
1121-58 A double-blind randomized dose finding study of gamma radiation for in-stent restenosis (2004) (0)
Acute angiographic and clinical results of the NIR w/SOX stent. (2002) (0)
Measures: Executive Summary Aortic Valve and Ascending Aorta Guidelines for Management and Quality (2013) (0)
TCT-106 Atrial Fibrillation is Associated with Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR: Insights From the PARTNER 2A and PARTNER 2 S3i Trials (2017) (0)
Incidence, Predictors, and PrognosticImpact of Late Bleeding Complications After Transcatheter Aortic Valve Replacement (0)
TCT-670 Treating LAD Disease with a Long Stent may be Associated with Increased Cardiac Mortality Independent of Other Ischemic Events (2017) (0)
Fate of nonflow-limiting dissections after treatment with iridium-192 therapy: results from the GAMMA I and II trials (2002) (0)
TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial. (2016) (0)
TAVR: From Concept to Clinical Reality (2012) (0)
THE IMPACT OF FRAILTY ON EARLY CHANGES IN PHYSICAL ACTIVITY AFTER TRANSCATHETER TRICUSPID VALVE REPAIR: AN ANALYSIS OF WEARABLE ACTIVITY MONITORING IN THE CLASP TR EARLY FEASIBILITY STUDY (2020) (0)
909-24 Intravascular Ultrasound Validation of a Semiquantitative Angiographic Classification of Coronary Artery Target Lesion Calcium (1995) (0)
MORPHOLOGIC PATTERNS OF IN-STENT CHRONIC TOTAL OCCLUSIONS: AN INTRAVASCULAR ULTRASOUND STUDY (2017) (0)
International Journal of Cardiovascular Interventions: Editorial (2003) (0)
Advances in Clinical Trials (2016) (0)
TCT-95 TEE- and Fluoroscopy-Guided WATCHMAN Implantation Without Administration of Iodinated Contrast Material (2021) (0)
ong-Term Clinical and Economic Analysis of the ndeavor Zotarolimus-Eluting Stent Versus the ypher Sirolimus-Eluting Stent (0)
TCT-16 Incidence, Outcomes, and Microbiologic Profile of Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from PARTNER (2018) (0)
INCIDENCE AND IMPACT OF ACUTE KIDNEY INJURY (AKI) POST TRANS-CATHETER AORTIC VALVE REPLACEMENT (TAVR) USING THE NEW VALVE ACADEMIC RESEARCH CONSORTIUM (VARC) CRITERIA (2012) (0)
Abstract 14059: Low Systemic Arterial Pressure and Greater Vascular Stiffness after Transcatheter Aortic Valve Replacement are Independently Associated with Mortality in the PARTNER I Trial and Registry (2014) (0)
Abstract 17258: The Relationship Between D-Dimer Levels and Deep Venous Thrombosis in COVID-19: An Analysis From a Quaternary Academic Medical Center in New York City (2020) (0)
TAVR AGE PARADOX: THE OLDEST PATIENTS HAVE BETTER THAN EXPECTED OUTCOMES IN THE PARTNER STUDY (2016) (0)
TCT-105 Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve Replacement (2013) (0)
TCT-707 Three-dimensional Echocardiographic Annular Sizing is Associated with Reduced Rates of Post-dilatation (2013) (0)
IMPACT OF POSTIMPLANT THERAPY ON CLINICAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS RECEIVING TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE (2021) (0)
Calling All Fellows and Program Directors: We Need Novel Solutions to Reinvent Interventional Fellowship (2023) (0)
Intracoronary stents (1995) (0)
1101-41 Intravascular ultrasound assessment of lesions with sirolimus-eluting stent failure (2004) (0)
Clinical site variability in radiographic imaging parameters and quality assurance standards (1996) (0)
Brachytherapy for in‐stent restenosis through the internal mammary artery (2001) (0)
Predictors of radiation failure after treatment of in-stent restenosis with gamma vascular brachytherapy: pooled analysis from GAMMA I, II, and SCRIPPS III studies (2002) (0)
Assimilated LVEF: A Bayesian technique combining human intuition with machine measurement for sharper estimates of left ventricular ejection fraction and stronger association with outcomes (2018) (0)
TCT-108 Debris heterogeneity across different valve types captured by a cerebral protection system during TAVR (2017) (0)
TCT-567 Long-Term Outcomes With an Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent Versus a Cobalt-Chromium Everolimus-Eluting Stent in Single De Novo Coronary Lesions: Four-Year Results of the TARGET I Randomized Controlled Trial (2015) (0)
Editorial (2001) (0)
TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
Efficacy of Long Radiation Treatment in Native In-Stent Restenosis: A Subanalysis From the RENO Registry (2002) (0)
Electrophysiolog ic Abnormalities inPatients WithHypertrophic Cardiomyopathy A Consecutive Analysis in155Patients (1989) (0)
Third generation of antisense drug inhibits c-myc expression after balloon angioplasty and stent implantation in the porcine coronary artery (2000) (0)
TCT-345 Detailed Segmental Comparison Between a Dedicated Bifurcation Stent and Balloon Angioplasty Using Intravascular Ultrasound and Three-dimensional Quantitative Coronary Angiography: a Subgroup Analysis of the Tryton IDE Randomized Trial (2015) (0)
Highlights from the 23rd Annual Transcatheter Cardiovascular Therapeutics Scientific Symposium, November 7-11, 2011, San Francisco, CA (2012) (0)
Percutaneous Coronary intervention in Small Coronary Arteries (2002) (0)
The NIR and NIRFLEX Coronary Stents (2001) (0)
Editorial (2003) (0)
CARDIAC CT PLANNING TO ACHIEVE COMMISSURAL ALIGNMENT WITH THE JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE DELIVERY SYSTEM (2023) (0)
TCT-299 Pulse Wave Velocity and Aortic Distensibility in Patients with Hypertensive Response Post Transcatheter Aortic Valve Replacement (2018) (0)
TCT-86 Quantification and Impact of the Proportion of Coronary Disease Burden Treated by Percutaneous Coronary Intervention: The SYNTAX Revascularization Index (2014) (0)
Site specific systemic delivery of rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model (2003) (0)
PREDICTORS OF AORTIC ROOT INJURY DURING BALLOON–EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION (2013) (0)
TCT CONNECT-359 In-Hospital Outcomes After Transcatheter Mitral Valve Repair With MitraClip in Patients With Chronic Kidney Disease: An Analysis From the 2010–2016 National Inpatient Sample (2020) (0)
TCT-316 Impact of Geographic Variation on the Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent: Results From the PIONEER III Clinical Trial in North America, Europe, and Japan (2021) (0)
SEX- AND RACE-BASED DIFFERENCES AMONG MEDICARE BENEFICIARIES UNDERGOING TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT IN THE UNITED STATES, 2012-2017 (2020) (0)
LOW AND ELEVATED B-TYPE NATRIURETIC PEPTIDE LEVELS ARE ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH PRESERVED EJECTION FRACTION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL AND REGISTRIES (2019) (0)
TCT-704 Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions: One Year Outcomes (2017) (0)
INSIGHTS INTO TIMING, RISK FACTORS, AND OUTCOMES OF NEUROLOGIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PARTNER-I TRIAL (2015) (0)
TCT-79 What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial (2017) (0)
TCT-656 Intravascular Ultrasound Morphologic Comparison of In-stent Chronic Total Occlusion Versus Non-Occlusive In-stent Restenosis (2017) (0)
TCT-786 The Effect of Post-dilatation on Outcome in the PARTNER 2B Trial (2013) (0)
A neural system dynamics modeling platform and its applications in randomized controlled trial data analysis (2021) (0)
Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy orEmbolization (0)
The glycoprotein IIb/IIIa inhibitors in PCI: A record of success (2002) (0)
PROGNOSTIC IMPLICATIONS OF DISCHARGE PATTERNS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (0)
Retreatment immediately after gamma radiation for in-stent restenosis results in need for target vessel revascularization beyond target lesion (2002) (0)
TCT-500 Prognostic Implications of Reduced Pre-procedural TIMI Flow in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing PCI (2018) (0)
1043-48 Impact of cerebrovascular and peripheral arterial disease on outcomes after percutaneous coronary interventions (2004) (0)
PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL (2009) (0)
TCT-196 Outcomes of Radial Compared with Femoral Artery Access in Patients Undergoing PCI for Left Main Disease: Analysis from the EXCEL Trial (2017) (0)
Predictors of target lesion revascularization in diabetic patients treated with Palmaz-Schatz stents (1998) (0)
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION WITHIN 6 MONTHS PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: A MULTICENTER CENTER STUDY WITH CENTRAL ANGIOGRAPHIC CORE LABORATORY ANALYSIS (2014) (0)
FIVE-YEAR OUTCOMES COMPARING SURGICAL VERSUS TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (0)
Short- Versus Long-TermDual Antiplatelet Therapy AfterDrug-Eluting Stent Implantation (2015) (0)
Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. (2017) (0)
Part II: Stent Revascularization of Carotid Bifurcation Disease (1997) (0)
THE RELATIVE PERFORMANCE CHARACTERISTICS AND CORRELATION OF THE LOGISTIC EUROSCORE AND THE SOCIETY OF THORACIC SURGERY SCORE IN THE PARTNER TRIAL (2013) (0)
CHARACTERIZATION OF WATCHMAN FLX DEVICE PROTRUSION INTO THE LEFT ATRIUM AND THE IMPLICATIONS FOR FUTURE TRANSCATHETER MITRAL REPLACEMENT (2023) (0)
NOVEL MODELING FOR PATIENT SPECIFIC PREDICTION OF TECHNICAL SUCCESS FOLLOWING MITRACLIPTMINTERVENTION - A NEURAL SYSTEM DYNAMICS ANALYSIS FROM THE COAPT TRIAL (2021) (0)
Abstract 906: Healing of Thin-Capped Fibroatheroma Assessed by Serial VH-IVUS Tissue Characterization (2008) (0)
The impact of new stent implantation on outcomes following intracoronary brachytherapy (2002) (0)
Can sirolimus-eluting stents tolerate some degree of geographic miss? (2003) (0)
1024-47 Sirolimus versus plain old balloon angioplasty small vessels (2004) (0)
INTRAVASCULAR ULTRASOUND COMPARISON BETWEEN CAUCASIAN AND ASIAN LEFT MAIN CORONARY ARTERY DISEASE (2011) (0)
TCT-299 The Impact of Left Ventricular Ejection Fraction on Long-Term Outcomes in Patients Undergoing PCI: Analysis From a Large Pooled Randomized Trial Dataset (2019) (0)
Abstract 4027: Different CAD Risk Factors Have Different Effects on Plaque Composition: An In Vivo Virtual Histology Intravascular Ultrasound (VH-IVUS) Analysis of 880 Patients from the Global VH Registry (2006) (0)
1063-65 Coronary blood flow velocity and myocardial perfusion with balloon occlusion and filter-based distal protection devices in saphenous vein graft stenting: Early experience of two centers (2004) (0)
Myocardial Cell Transplantation Catheter-Based Autologous Bone Marrow Myocardial Injection in No-Option Patients With Advanced Coronary Artery Disease (2016) (0)
1989:515-REPORTS ON HYPERTENSION Comparative Effects of Verapamil and Nitroprusside on Left Ventricular Function in Patients With Hypertension (2016) (0)
Predictors and prognostic values of CK-MB cardiac enzyme elevation after coronary intervention with radiation treatment in in-stent restenosis (2002) (0)
TCT CONNECT-314 Impact of Body Surface Area on Left Main Lumen Area (2020) (0)
Injection of autologous bone marrow in the heart muscle (2000) (0)
TCT-590 Three-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Single De Novo Native Coronary Lesions: The TARGET I Trial (2014) (0)
Editorial (2001) (0)
DRUG-ELUTING STENTS : TAXUS-IV ender-Based Outcomes After aclitaxel-Eluting Stent Implantation n Patients With Coronary Artery Disease (2005) (0)
TCT-140 Impact of Left Ventricular Mass Regression on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER 1 and 2 Trials and Registries (2019) (0)
1018-52 Volumetric Intravascular Ultrasound Volumetric Analysis Shows that Small Stent Size and Intimal Hyperplasia Contribute to Restenosis (1995) (0)
Intravascular Ultrasound Analysis Bifurcation Coronary Lesions Treated With the "Crush" Technique: An (2011) (0)
THE PRESENCE OF A PACEMAKER IS ASSOCIATED WITH INCREASED 1 YEAR MORTALITY AND REHOSPITALIZATION IN THE PARTNER TRIAL (2014) (0)
Gamma vascular brachytherapy neutralizes the negative impact of diabetes mellitus on clinical outcomes after PCI for in-stent restenosis: pooled data from Gamma I, Gamma II, and SCRIPPS III trials (2002) (0)
TCT-860 Comparison Between Cardiac Computed Tomography and Three-Dimensional Echocardiography for the Evaluation of Patients with Severe Tricuspid Regurgitation (2017) (0)
TCT-74 Baseline Left Ventricular Hypertrophy and 5-Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries (2019) (0)
TCT-395 A Propensity-Matched Comparison of Suprasternal and Transfemoral Transcatheter Aortic Valve Replacement: Inominate versus Femoral (2018) (0)
Abstract 16606: The Impact of Learning Curve on Success and Adverse Events After Transcatheter Aortic Valve Replacement: A PARTNER Substudy (2013) (0)
A sensitive and cost-effective intravascular ultrasound model to study anti-restenosis strategies in vivo (1996) (0)
Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of &ggr;-Brachytherapy for the Treatment of In-Stent Restenosis (2002) (0)
TCT-249 Differential Impact Of Diabetes Mellitus On Safety And Efficacy Of New Versus First Generation Drug-eluting Stents Among Women: A Patient-level Pooled Analysis Of 26 Randomized Trials (2014) (0)
LEFT VENTRICULAR REMODELING AFTER JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH PURE AORTIC REGURGITATION (2022) (0)
EFFECT OF SEX AND LOW FLOW AFTER SURGICAL OR TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS OF PARTNER 2 AND 3 TRIALS (2022) (0)
TCT-290 Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus: Results From the PIONEER III Clinical Trial (2021) (0)
TCT-256 Impact of Coronary Artery Tortuosity on PCI Outcomes: An Individual Patient-Data Pooled Analysis From 6 Randomized Controlled Trials (2018) (0)
Use of Routine Echocardiographic Screening for Structural Heart Disease in At-Risk Pregnant Women in India. (2020) (0)
Cardiac Computed Tomography Angiography Anatomical Characterization of Patients Screened for a Dedicated Transfemoral Transcatheter Valve System for Primary Aortic Regurgitation (2023) (0)
Delayed time course of target lesion revascularization following saphenous vein graft angioplasty (1998) (0)
Transseptal Access-Gateway to Transcatheter Mitral Interventions. (2019) (0)
Abstract 4215: Intravascular Ultrasound Evaluation of Both the Left Anterior Descending and Left Circumflex Branches After Left Main Bifurcation Stenting (2009) (0)
TCT CONNECT-494 Importance of Symptom and Activity Improvement for Patients With Tricuspid Regurgitation (TR) (2020) (0)
TCT-34 Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial. (2016) (0)
1044-57 Initial experience with sirolimus-eluting stents in left main no option patients: Data from the SECURE trial (2004) (0)
The “dark side” of overly aggressive multidevice atherectomy (1996) (0)
TCT-898 Incidence and Impact of Acquired Thrombocytopenia on Bleeding Events and Mortality after Transcatheter Aortic Valve Replacement (TAVR) (2012) (0)
1101-43 Longitudinal vessel remodeling pattern following sirolimus-eluting stent implantation: Analysis of vessel integrity throughout target segment (2004) (0)
IMPACT OF ANNULAR OVERSIZING ON PARAVALVULAR REGURGITATION AND VALVE HEMODYNAMICS: NEW INSIGHTS FROM THE PARTNER 3 TRIAL (2021) (0)
THE ROLE OF VENTRICULAR STROKE WORK AND VASCULAR IMPEDANCE IN DEFINING AORTIC STENOSIS (2018) (0)
INCIDENCE AND OUTCOMES OF PATIENTS REQUIRING SURGICAL BAIL-OUT DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: A REPORT FROM THE NCDR® STS/ACC TRANSCATHETER VALVE THERAPY (TVT) REGISTRY (2017) (0)
Prolonged antiplatelet therapy after coronary brachytherapy: When is it safe to stop clopidogrel? (2003) (0)
TCT-134 Current Management and Disparities in Care for Patients With Symptomatic Severe Aortic Regurgitation (2019) (0)
Iatrogenic Atrial Septal Defects After Transseptal Transcatheter Mitral Valve Replacement With a Balloon-Expandable Valve. (2023) (0)
IN-HOSPITAL OUTCOMES AFTER TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE 2012-2015 NATIONAL INPATIENT SAMPLE (2019) (0)
CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH PRIOR CHEST RADIATION UNDERGOING TAVR: OBSERVATIONS FROM THE PARTNER 2 TRIAL AND REGISTRIES (2018) (0)
WORSENING TRICUSPID REGURGITATION AND INCREASED MORTALITY AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER2A (2017) (0)
THE ALIGNMENT OF TRANSCATHETER AORTIC VALVE NEO-COMMISSURES (ALIGN TAVR) STUDY (2020) (0)
Reproducibility and Biologic Variability of Volumetric Intravascular Ultrasound Measurements (1998) (0)
TCT-844 Very Late (>1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials (2019) (0)
A serial volumetricintravascular ultrasound analysis of instent restenosis (1996) (0)
In vivovalidation of lesion length measurements using motorized pullback of intravascular ultrasound transducers (1996) (0)
Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply. (2020) (0)
Is bigger better with vascular brachytherapy (VBT) for in-stent restenosis? Impact of optimal final angiographic results and predictors of restenosis in 990 VBT patients (2002) (0)
Practical integration of intravascular ultrasound imaging into the cardiac catheterization laboratory (1996) (0)
Abstract 2161: Impact of Target Lesion Revascularization During the First Year After Bare-Metal or Sirolimus-Eluting Stenting on Five-Year Cardiac Outcomes (2007) (0)
Expression Following Delivery to Porcine Myocardium (2002) (0)
Erratum: Bifurcation coronary lesions treated with the "crush" technique: An intravascular ultrasound analysis (Journal of American College of Cardiology (2005) 46 (599-605)) (2005) (0)
arly Experience With Percutaneous ranscatheter Implantation of Heart Valve rosthesis for the Treatment of End-Stage noperable Patients With Calcific Aortic Stenosis (2016) (0)
TCT-419 Predictors of 5-Year Mortality After PCI: An Individual Patient-Data Pooled Analysis of 32,882 Patients From 21 Randomized Controlled Trials (2019) (0)
Management of patients with hypertrophic cardiomyopathy (1991) (0)
TCT CONNECT-311 Left Main Lesion Assessment: A Comparison of Angiographic and IVUS Findings (2020) (0)
REDUCED BASELINE EJECTION FRACTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR MORTALITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER II TRIALS (2018) (0)
Smooth Muscle Cell Abundance and Fibroblast Growth Factors in Coronary Lesions of Patients (2005) (0)
[Clinical application of intracoronary ultrasound]. (1997) (0)
Abstract 899: Distribution of Thin-Cap Fibroatheroma and Necrotic Core after Stenting in Patients With Acute Coronary Syndrome: A Virtual Histology Intravascular Ultrasound Study (2008) (0)
Abstract 3438: Impact of Different Pre-dilatation Strategies on Stent Expansion: An Intravascular Ultrasound Study (2006) (0)
Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data. (2022) (0)
‘Optimal’ Directional Coronary Atherectomy (1998) (0)
Safety of Intracoronary g -Radiation on Uninjured Reference Segments During the First 6 Months After Treatment of In-Stent Restenosis A Serial Intravascular Ultrasound Study Brief Rapid Communication (2000) (0)
REFINING THE CLASSIFICATION OF SEVERE, SYMPTOMATIC AORTIC STENOSIS USING FLOW AND GRADIENT MEASUREMENTS TO PREDICT OUTCOMES POST-TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
TCT CONNECT-98 Impact of Flow on the Incidence and Prognosis of Prosthesis-Patient Mismatch Following Aortic Valve Replacement in the PARTNER 2 Study and Registry (2020) (0)
TCT CONNECT-490 Health Status Improvements Following Transcatheter Tricuspid Repair With the PASCAL Device in the CLASP TR Early Feasibility Study (2020) (0)
Immediate and long-term outcomes following carotid stenting for patients with restenosis post carotid endarterectomy: A multi-centre registry (2000) (0)
Injection intramyocardique de moelle osseuse autologue (2000) (0)
D-2 | Cardiac Computed Tomography Angiography Anatomical Characterization of Patients with Primary Aortic Regurgitation (2022) (0)
TCT-51 Impact of anticoagulation therapy on valve hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A pooled analysis of the PARTNER2 trials (2017) (0)
ACHIEVEMENT OF GUIDELINE DIRECTED MEDICAL THERAPY GOALS IN COMPLEX HIGHER-RISK (AND INDICATED) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
Real-time intracoronary ultrasound imaging: In vitro pulse duplicator studies and preliminary in vivo results (1990) (0)
RIGHT ATRIAL PRESSURE IN PULMONARY HYPERTENSION ASSESSMENT IN TRICUSPID REGURGITATION (2023) (0)
Prior infection with cytomegalovirus markedly increases the risk of restenosis following directional coronary atherectomy (1996) (0)
Transcatheter Valve Therapies: Current and Future Application (2014) (0)
TCT-400 2-Year Clinical Follow-up of the TRYTON IDE Randomized Trial Comparing a Dedicated Bifurcation Stent to Provisional Stenting in the Treatment of Coronary Bifurcations (2015) (0)
ANNULUS ASSESSMENT PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: ANNULUS DIMENSIONS MAY NOT BE LARGEST IN MID-SYSTOLE (2016) (0)
STRUCTURAL VALVE DETERIORATION OF TRANSCATHETER VERSUS SURGICAL AORTIC VALVES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE PARTNER 2A TRIAL AND SAPIEN 3 INTERMEDIATE RISK REGISTRY (2021) (0)
IMPACT OF TRANSCATHETER TRICUSPID VALVE REPAIR ON DAILY PHYSICAL ACTIVITY: AN ANALYSIS OF WEARABLE ACTIVITY MONITORING IN THE CLASP TR EARLY FEASIBILITY STUDY (2020) (0)
Abstract 3347: Sirolimus Eluting Stents In Single Vessel Versus Multi-vessel Percutaneous Coronary Intervention: Results From The Matrix Registry (2007) (0)
TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial (2018) (0)
Aortic Valve Annular Sizing (2017) (0)
Type of Arterial Remodeling in Intermediate Coronary Artery Stenosis (2003) (0)
934-26 Comparison of Intravascular Ultrasound and Coronary Angiography in the Assessment of Target Lesion Plaque Distribution in Coronary Artery Disease (1995) (0)
Mechanismsand Resultsof Balloon Angioplasty for the Treatmentof In-Stent Restenosis (1996) (0)
HIGH BASELINE VALVULOARTERIAL IMPEDENCE PREDICTS WORSE 1-YEAR OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
Direct myocardial revascularization: Surgical and catheter-based approaches (2002) (0)
Editorial comment: Transseptal approach to aortography and carotid artery stenting in pulseless disease (1997) (0)
Abstract 909: Natural History of Coronary Artery Lesion Morphology Assessed by Serial VH-IVUS Tissue Characterization (2008) (0)
TCT-714 Association of Statin and Mortality after Transcatheter Aortic Valve Replacement (2018) (0)
Does the RCA differ from the LAD after coronary stenting (1998) (0)
TCT-546 Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease. (2016) (0)
ACCELEROMETER-MEASURED PHYSICAL ACTIVITY RECOVERY IN THE FIRST MONTH AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
TCT-327 Calcium Volume Score on Contrast-Enhanced Computed Tomography Prior to Transcatheter Aortic Valve Replacement: what’s the most accurate threshold cutoff? (2015) (0)
PREVALENCE AND PREDICTORS OF LONG-TERM TARGET VESSEL AND NON-TARGET VESSEL MYOCARDIAL INFARCTION AFTER PCI: A PATIENT LEVEL ANALYSIS INTEGRATING DATA FROM 12 CLINICAL TRIALS (2018) (0)
TCT-666 Safety Evaluation of the Biodegradable Polymer-Based Sirolimus-Eluting Stent with Faster Drug Eluting Rate and Polymer Absorption Kinetics in Complex Patient and Lesion Subgroup of the PANDA III Trial (2018) (0)
Targeted Lesion Subsets and Anticoagulatlon Regimens After Balloon and New Device (2005) (0)
TCT-2 Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement in Moderate-Risk Patients: A Pooled PARTNER 2 Trial and Registry Study (2019) (0)
Abstract 2546: Are Lesions that Appear Echolucent on Greyscale IVUS Imaging “Vulnerable”? A Virtual Histology Intravascular Ultrasound Analysis (2008) (0)
909-26 There are Gender-Related Differences in Vessel Size, but not In Target Lesion Plaque Composition: A Pre-Intervention Intravascular Ultrasound Study (1995) (0)
Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real‐world comparative analysis (2022) (0)
Palmaz-Schatz stent implantation in the treatment of saphenous vein graft lesions. (1995) (0)
Angiographic findings after minimally invasive coronary bypass operation: an angiographic study (1998) (0)
Highlights of Transcatheter Cardiovascular Therapeutics 2019. (2019) (0)
OUTCOMES OF DIABETIC PATIENTS UNDERGOING PCI WITH CONTEMPORARY DRUG-ELUTING STENTS: ANALYSIS FROM THE BIONICS STUDY (2018) (0)
PREVENTION OF CARDIAC MATERNAL MORTALITY IN THE DEVELOPING WORLD: SCREENING PREGNANT WOMEN IN HYDERABAD, INDIA FOR STRUCTURAL HEART DISEASE (2020) (0)
Abstract 1145: Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis from 14 Randomized Clinical Trials (2008) (0)
TCT-18 Impact of Incomplete Revascularization after Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease: A SEEDS Substudy (2015) (0)
Long-term safety and effectiveness of sirolimus-eluting stent implantation (SIRIUS Study) (2009) (0)
TCT-97 Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation following Transcatheter Aortic Valve Replacement (2012) (0)
TCT-386 Long-Term Outcomes After Left Main PCI: An Individual Patient-Data Pooled Analysis of 21 Randomized Controlled Trials (2019) (0)
TCT-182 Outcomes Following Left Main PCI vs. CABG in Patients With Cerebrovascular Disease: Results From the EXCEL Trial (2017) (0)
TCT-3 Modified Body Mass Index, A Novel Marker of Malnutrition and Clinical Frailty, is Associated With Outcomes After Transcatheter and Surgical Aortic Valve Replacement (2019) (0)
TCT-891 Outcomes Of Transcatheter Aortic Valve Replacement Versus Standard Therapy Among Women Deemed Too High Risk For Surgery In The PARTNER Trial (2012) (0)
Abstract 21201: Stent Length Remains an Important Risk for Recurrent Events in Women With or Without Diabetes Mellitus After New Generation DES PCI: From the WIN DES Collaboration (2017) (0)
TCT-538 Bleeding Outcomes in Patients Undergoing Combined TAVR/PCI: Time for an Adjustment to the CathPCI Bleeding Model? (2018) (0)
Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of -Brachytherapy for the Treatment of In-Stent Restenosis (2002) (0)
TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis. (2016) (0)
POOLED ANALYSIS OF LONG–TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM (2012) (0)
Anatomical Considerations and Emerging Strategies for Reducing New Onset Conduction Disturbances in Percutaneous Structural Heart Disease Interventions (2021) (0)
Long-Term Outcomes of Randomized Controlled Trials Comparing Percutaneous Left Atrial Appendage Closure to Oral Anticoagulation for Nonvalvular Atrial Fibrillation: A Meta-Analysis (2022) (0)
Mechanistic comparison of rotational atherectomy and excimer laser angioplasty in the treatment of in-stent restenosis: a volumetric intravascular ultrasound study (1998) (0)
IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 COHORT A TRIAL (2019) (0)
1285Progression of tricuspid regurgitation over time and outcome: new insights in the natural history (2017) (0)
Beta versus gamma radiation for treatment of in-stent restenosis: angiographic predictors and outcomes in 630 patients (2002) (0)
30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS (2021) (0)
Catheter-based brachytherapy for aorto-ostial in-stent restenosis (2002) (0)
EARLY IMPROVEMENT IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FUNCTION IN TRANSCATHETER COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT (2014) (0)
TCT-314 Inpatient Versus Outpatient PCI in Patients With Left Main Disease: Analysis From the EXCEL Trial (2019) (0)
TCT-584 Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials (2018) (0)
Acute and long-term outcomes of multivessel stenting in patients aged 80 years (2003) (0)
How Does Caffeine Increase Exercise Capacity But Decrease Myocardial Flow Reserve ? (2006) (0)
Long-term clinical results and predictors after successful stent implantation in saphenous vein grafts (1998) (0)
TCT-834 Risk Stratification Using the ACEF Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization: Insights From the EXCEL Trial (2018) (0)
Optimal Stent Expansion: An Intrsvasculsr Ultrasound Study (2013) (0)
TCT 2009: New Findings Pave the Way for Novel Approaches to Treating Cardiovascular Disease (2010) (0)
Coronary brachytherapy is an effective treatment for chronic in-stent total occlusions (2003) (0)
LONG-TERM OUTCOMES OF PATIENTS TREATED WITH ZOTAROLIMUS-ELUTING STENTS IN DIFFERENT INDICATIONS: ST ELEVATION MYOCARDIAL INFARCTION VERSUS ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION VERSUS STABLE ANGINA: A POOLED ANALYSIS FROM THE RESOLUTE PROGRAM (2012) (0)
utcomes With the Paclitaxel-Eluting tent in Patients With Acute Coronary Syndromes (2005) (0)
TCT-384 The Myocardial Contraction Fraction Predicts Adverse Events after Aortic Valve Replacement: An Analysis of 3,259 Patients from the Pooled PARTNER 2 Database (2017) (0)
792-2.Is the Anti-Restenosis Effect of Stent (vs PTCA) Greater in LAD Vessels? A Subgroup Analysis of the STent REStenosis Study (1995) (0)
822-4 Intravascular ultrasound follow-up of the SECURE trial: The compassionate use of sirolimus-elutings stents study (2004) (0)
International Journal of Cardiovascular Intervention (2001) (0)
FOUR-YEAR OUTCOMES FOLLOWING RESOLUTE ZOTAROLIMUS-ELUTING STENT IMPLANTATION: RESOLUTE US STUDY (2014) (0)
Balloon Angioplasty in Patients With Femoropopliteal Occlusions (2005) (0)
COMPARISON BETWEEN THREE-DIMENSIONAL ECHOCARDIOGRAPHY AND COMPUTED TOMOGRAPHY FOR TRICUSPID ANNULUS SIZING: IMPLICATIONS FOR THE GRADING OF TRICUSPID REGURGITATION USING THE QUANTITATIVE DOPPLER METHOD (2018) (0)
SIMILAR OUTCOMES WITH THE SUPREME™BIODEGRADABLE DRUG COATED CORONARY STENT SYSTEM IN ACUTE CORONARY SYNDROME AND CHRONIC CORONARY SYNDROMES: RESULTS OF THE PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED PIONEER III TRIAL (2021) (0)
The “Lollipop” During Catheter-Directed Thrombectomy (2022) (0)
P1966Impact of coronary artery calcification on long-term outcomes after implantation of first and second-generation drug-eluting stents: a patient-level analysis of 18 randomized trials (2019) (0)
TCT-266 Complications of Indwelling Urinary Catheters In Patients Undergoing Transcatheter Aortic Valve Replacement (2017) (0)
THE EFFECT OF OVERSIZING ON THE HEMODYNAMIC PERFORMANCE OF THE SAPIEN 3 TRANSCATHETER HEART VALVE (2015) (0)
TCT-103 Wire Location by IVUS Strongly Predicts Procedural Success in the Retrograde Approach for Chronic Total Occlusions (2019) (0)
Effects of Transcendental Meditation on Symptoms and Electrocardiographic Changes in Patients With Cardiac Syndrome X (2000) (0)
TCT-663 Anatomic and Procedural Predictors of Paravalvular Leak following Transcatheter Aortic Valve Replacement with a Self-expanding Prosthesis at a High Volume Center Including a Novel Variable of Inflow Expansion (2015) (0)
TCT-82 Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (WoRldwIde TAVR ExperieNce) Survey. (2016) (0)
TCT-119 Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset (2018) (0)
Clinical Trial Five-Year Clinical Follow-Up After Intracoronary Radiation : Results of a Randomized (2002) (0)
TCT-109 Inaccuracy of FFR in Clinical Practice: A High-Volume Single-Center Experience (2019) (0)
TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry. (2013) (0)
TCT-84 Procedural Strategy and Clinical Outcomes in Patients Undergoing PCI for Left Main Trifurcation Disease: The EXCEL trial (2017) (0)
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy (2023) (0)
Percutaneous coronary interventions in octogenarians with use of glycoprotein GP llb/llla inhibitors: Similar major adverse cardiac events but higher hemorrhagic stroke rate than younger patients (2003) (0)
Predictors of contrast induced nephropathy after percutaneous coronary intervention in patients with and without chronic renal failure (2002) (0)
Does genetic polymorphism for platelet glycoprotein illa impact early and long-term outcomes after elective percutaneous coronary interventions? (2003) (0)
TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
Arterial remodeling in left main coronary disease: proof from serial volumetric intravasculer ultrasound studies (1998) (0)
TCT-307 Vascular Closure Device Use After PCI for Left Main Disease: Analysis From the EXCEL Trial (2019) (0)
ASSOCIATION BETWEEN LEFT VENTRICULAR EJECTION FRACTION IMPROVEMENT AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT AND 5-YEAR SURVIVAL: AN ANALYSIS OF THE PARTNER TRIALS AND REGISTRIES (2021) (0)
Vascular brachytherapy for ostial in-stent restenotic lesions (2002) (0)
Intravascular Ultrasonic Comparison of the Arterial Remodeling after Directional Coronary Atherectomy and Mechanical Rotational Atherectomy (1994) (0)
LONG-TERM ADVERSE ISCHEMIC OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS BY PRIOR CORONARY ARTERY BYPASS GRAFTING STATUS: ANALYSIS FROM 19 RANDOMIZED TRIALS (2020) (0)
1139-56 Impact of stent implantation techniques on stent edge neointimal hyperplasia following sirolimus-eluting stenting (2004) (0)
Abstract 18932: Safety and Efficacy of New- vs. Early-Generation Drug-Eluting Stents in Elderly Women: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (0)
TCT-93 Improvement in Renal Function and its Impact on All-cause Mortality after Transcatheter Aortic Valve Replacement (TAVR): Experience from the PARTNER Trial (2015) (0)
Abstract 19992: Impact of Successful Percutaneous Coronary Intervention of a Chronic Total Occlusion: Five-Year Outcomes from a 1,781 Patient Multinational Registry (2010) (0)
1116-7 Similar outcomes between patients with native coronary and bypass graft disease treated with sirolimus-eluting stents in the SECURE trial (2004) (0)
Abstract 20362: Gender Differences in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,781 Patient Multinational CTO Registry (2010) (0)
710-4 The Dimorphic Pathology of Vein Graft Lesions Effects Acute Procedural and Late Angiographic Outcomes (1995) (0)
TCT-477 Prevalence and Clinical Impact of Baseline QRS Duration in Patients With Severe Aortic Stenosis Two Years After Aortic Valve Replacement in the PARTNER II Trial (2018) (0)
Intravascular ultrasound guidance decreases target lesion revascularization in long-diffuse coronary lesions (2002) (0)
Faculty of 1000 evaluation for Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2018) (0)
1101-63 Impact of preinterventional lesion calcification on neointimal hyperplasia following sirolimus-eluting stent implantation: An intravascular ultrasound analysis (2004) (0)
TCT-20 Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I Trial (2013) (0)
LONG-TERM (FIVE-YEAR) CLINICAL EVALUATION OF THE RESOLUTE CORONARY ZOTAROLIMUS-ELUTING STENT: THE RESOLUTE US CLINICAL TRIAL (2015) (0)
TRANSCATHETER AORTIC VALVE REPLACEMENT RESULTS IN SIGNIFICANT REVERSE REMODELING IN PATIENTS WITH LEFT VENTRICULAR DILATION: A REPORT FROM THE PARTNER I TRIAL (2015) (0)
TCT CONNECT-411 IVUS Characteristics of Stent Edge Hematoma Associated With Acute Occlusion (2020) (0)
Interaction between secondary mitral regurgitation and left atrial function and their prognostic implications after cardiac resynchronization therapy (2022) (0)
Physiologic assessment of serial lesions: Comparison of present methodologies (2003) (0)
Introduction. Forces of change in interventional vascular medicine: outlook for the next millennium. (1998) (0)
TCT-85 Mechanisms of In-Stent Restenosis in the Ostial Right Coronary Artery (2021) (0)
Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: evaluations by three-dimensional coronary angiography, optical coherence tomography (2015) (0)
SAFETY AND FEASIBILITY OF PERCUTANEOUS MITRAL BALLOON VALVULOPLASTY IN PATIENTS WITH SEVERE MITRAL STENOSIS SECONDARY TO SEVERE MITRAL ANNULAR CALCIFICATION (2022) (0)
Prognostic Value of N-terminal Pro-brain Natriuretic Peptide in Patients Undergoing Percutaneous Coronary Intervention with Left Main Coronary Artery Disease (2014) (0)
TCT-578 Predictive Factors of Early, Late and Very Late Atherothrombotic Events in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
Analysis of Early Out-of Hospital Mortality after Transcatheter Aortic Valve Implantation among Patients with Aortic Stenosis Successfully Discharged from the Hospital and Alive at 30 days (From the PARTNER Trial) (2015) (0)
Abstract 18892: Clinical and Hemodynamic Factors Influence the Risk of Pulmonary Hypertension in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights from the PARTNER I Trial and Registry (2014) (0)
MULTI-VESSEL PCI AND CABG DEMONSTRATE SIGNIFICANT IMPROVEMENTS IN POST-PROCEDURE GLOBAL LONGITUDINAL STRAIN AND LEFT VENTRICULAR EJECTION FRACTION (2022) (0)
Outcomes of Inoperable Symptomatic Aortic Stenosis Patients Not Undergoing Aortic Valve Replacement Insight Into the Impact of Balloon Aortic Valvuloplasty From the PARTNER (Placement of (2017) (0)
Abstract 18221: Flow Characteristics of CoreValve Transcatheter Aortic Valve: Implications for Calculation of Stroke Volume and Effective Orifice Area (2015) (0)
TCT-199 Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Long Lesions: 1-Year Outcomes from the Randomized BIONICS Trial (2018) (0)
Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (2017) (0)
Do multiple prior interventions for in-stent restenosis impact the success of gamma brachytherapy? (2002) (0)
Aortic Valve Disease Interventions (2011) (0)
TCT-693 Influence of Body-Mass-Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on Obesity-Paradox from The PARTNER Trial (2014) (0)
TCT-646 Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent (2012) (0)
Angioplast Using Urokinase- Coated Hydrogel Balloons (2005) (0)
Identification of “plaque-free” reference segments using standard quantitative angiography (1996) (0)
Is calcium a sensitive marker for coronary atherosclerosis? An intravascular ultrasound study of 1548 native arteries (1996) (0)
A CROSSOVER BALLOON OCCLUSION TECHNIQUE FOR PERCUTANEOUS CLOSURE AFTER TRANS-FEMORAL AORTIC VALVE IMPLANTATION (2010) (0)
TCT-474 Ultra-Low Contrast Coronary Angiography in Patients with Advanced Chronic Kidney Disease - Feasibility and Outcomes Compared to Standard Angiography (2017) (0)
TCT-265 Impact of Peri-procedural Complications on Mortality and Quality of Life after TAVR (2017) (0)
Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial (2018) (0)
EARLY IMPROVEMENT IN FLOW (LEFT VENTRICULAR STROKE VOLUME INDEX) AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN LOW-FLOW AORTIC STENOSIS (2015) (0)
1121-56 Earlier time to restenosis predicts outcomes following gamma vascular brachytherapy (2004) (0)
THREE–YEAR FOLLOW–UP OF THE RESOLUTE US CLINICAL TRIAL (2013) (0)
TCT-788 Relationship between total CK, CK-MB, SCAI, and Universal Definition in determining peri-PCI Myocardial Infarction: analysis from the Randomized BIONICS Trial (2018) (0)
Usefulness of Providing Physicians the Results of Risk Factor Assessments and Treatment Recommendations at Discharge After Coronary Artery Bypass Grafting (2000) (0)
Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial (2022) (0)
Abstract 18371: Regression of LV Mass After Transcatheter or Surgical Aortic Valve Replacement for Aortic Stenosis in the PARTNER I Trial (2013) (0)
TRENDS IN TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT AMONG MEDICARE BENEFICIARIES IN THE UNITED STATES, 2012-2017 (2020) (0)
2 YEAR CLINICAL OUTCOMES FROM THE PIVOTAL RESOLUTE US STUDY (2012) (0)
Interventional vascular therapy: past experiences and future directions. Introduction. (1998) (0)
822-5 Impact of radiation dose on outcomes in diabetic patients: Results from the SCRIPPS IV trial (2004) (0)
TCT-499 Prognostic Implications of Pre-procedural TIMI Flow in Patients with STEMI Undergoing PCI with Drug-Eluting Stent Implantation (2018) (0)
TCT-425 Impact of cerebral protection in aortic stenosis patients treated with transcatheter aortic valve replacement on functional and structural integrity of the brain: results of a combined patient-level analysis of three randomized controlled trials (2017) (0)
Abstract 11227: Ischemia Mediated Contractile Dysfunction Modulates Functional Mitral Regurgitation - Multiparametric Strain and Tissue Characterization Data from the Society of Cardiovascular Magnetic Resonance (scmr) Registry (2021) (0)
The clinical outcomes on percutaneous coronary intervention for ostial and/or midshaft lesions versus distal bifurcation lesions from the DELTA registry: a multicenter registry evaluating percutaneous (2013) (0)
The use of verapamil in the treatment of hypertrophic cardiomyopathy (1987) (0)
Abstracts Fifth International and Interdisciplinary Symposium on Endoluminal Stents and Grafts (2007) (0)
TCT-605 Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 2-Year Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET II Trials (2014) (0)
THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
ASSESSMENT OF INTERVENTIONAL CARDIOLOGY FELLOWS’ ABILITIES IN INTRACORONARY PHYSIOLOGY AND IMAGING (2021) (0)
Valve replacement for pure native aortic regurgitation from alpha to omega: Severe aortic regurgitation: A 20 years search for an adequate transcatheter heart valve device. (2022) (0)
TCT-443 Short-Term Outcomes of Orbital Mechanical Atherectomy in Patients With Severe Aortic Stenosis (2021) (0)
INTER-CORE LAB VARIABILITY IN ANALYZING QUANTITATIVE CORONARY ANGIOGRAPHY FOR BIFURCATION LESIONS: A POST-HOC ANALYSIS OF A RANDOMIZED TRIAL (2015) (0)
1155-78 Implications and prevention of large periprocedural myocardial infarction after percutaneous intervention of diseased saphenous vein grafts and thrombotic native coronary lesions (2004) (0)
Abstract 19106: Diabetes Induced Actin S-glutathiolation Increases Vein Graft Accelerated Atherosclerosis Through Delayed Endothelial Regeneration (2014) (0)
Transcatheter Cardiovascular Therapeutics 2018. (2019) (0)
TCT-93 Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis (2012) (0)
Transplantation of autologous endothelial cells induces angiogenesis in a sheep model of chronic ischemia (2003) (0)
WHAT IS THE UNDERLYING PLAQUE MORPHOLOGY OF CORONARY THROMBOSIS? AN ANGIOSCOPIC AND VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND CORRELATIVE STUDY (2010) (0)
REDUCTION OF PARA-VALVULAR REGURGITATION WITH POST-DILATATION FOLLOWING BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
ole of the Endothelium in odulating Neointimal Formation asculoprotective Approaches to Attenuate estenosis After Percutaneous Coronary Interventions (2004) (0)
Early outcomes following transatrial transcatheter mitral valve replacement in patients with severe mitral annular calcification. (2022) (0)
Geographic miss is not associated with restenosis or the edge phenomenon in the INHIBIT trial (2002) (0)
Stenting in acute myocardial infarction in patients with chronic renal failure: predictors of in-hospital and long-term outcome (2002) (0)
LONG-TERM CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC TOTAL OCCLUSIONS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: FIVE-YEAR OUTCOMES FROM A 1,791 PATIENT MULTI-NATIONAL REGISTRY (2011) (0)
COMMISSURAL ALIGNMENT AFTER TRANSFEMORAL DELIVERY OF THE JENAVALVE TRANSCATHETER AORTIC VALVE (2021) (0)
TCT-709 Hemodynamic Outcomes of Post-dilatation in Transcatheter Aortic Valve Replacement (2013) (0)
Impact of Arterial Remodeling on Stent Expansion (2003) (0)
TCT-18 Feasibility, safety and outcomes of chronic total occlusion revascularization in end-stage renal disease (2017) (0)
Treatment Options for Coronary Revascularization (1999) (0)
LONG-TERM OUTCOMES FOLLOWING STENT IMPLANTATION IN PATIENTS WITH VERSUS WITHOUT PRIOR PCI: AN INDIVIDUAL PATIENT-DATA POOLED ANALYSIS OF 20 RANDOMIZED CONTROLLED TRIALS (2020) (0)
Endoluminal Transplantation of Endothelial Cells (2003) (0)
DOES PATIENT PROSTHESIS MISMATCH DEFINED BY CT LVOT AREA PREDICT DOWNSTREAM CLINICAL OUTCOMES (2017) (0)
Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials (2022) (0)
Percutaneous Implantation of Valvular Aortic Bioprosthesis: Reconciling the Clinical and Economi Values of an Established Treatment (2013) (0)
Clinical implications of myocardial perfusion status assessed by myocardial blush after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial (2003) (0)
TCT-38 Paravalvular Regurgitation Regression and Impact on 1-year Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 Transcatheter Valve. (2016) (0)
PATTERNS OF LEFT VENTRICULAR REMODELING IN PATIENTS WITH SEVERE AORTIC STENOSIS IN THE PARTNER TRIAL (2014) (0)
Abstract 15617: Atrial Fibrillation Prevalence, Anticoagulation Practices, and Long-term Outcomes for Patients Discharged With Atrial Fibrillation After Tavr: Results From the Partner 2a and S3i Trials (2020) (0)
TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
TCT CONNECT-39 Long-Term Outcomes After Drug-Eluting Stent Implantation in Thrombotic Lesions: An Individual Patient-Data Pooled Analysis of 8 Randomized Controlled Trials (2020) (0)
ECG GATED PRESSURE VOLUME RELATIONSHIPS UTILIZING SCINTIGRAPHIC IMAGE DATA. (1987) (0)
TCT-795 Prognostic Impact of Race in Patients Undergoing PCI: Analysis of 22,638 Patients from 10 Randomized Coronary Stent Trials (2018) (0)
Early Surgical Aortic Valve Replacement vs Watchful Waiting for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled Trials (2022) (0)
TCT-697 Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights From the PARTNER Trial (2014) (0)
Sequential Intravascular Ultrasound Characterization of the Mechanisms of Rotational Atherectomy and Adjunct BaRew An plasty (2016) (0)
Cervical Carotid Atherosclerosis: Medicine Versus Surgery; Endarterectomy Versus Stents (1999) (0)
TCT CONNECT-82 Prognostic Value of Serial Neutrophil-to-Lymphocyte Ratio in Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement: The PARTNER I-II Trials and Registries (2020) (0)
Abstract 18702: Obesity Paradox in Women Undergoing Percutaneous Coronary Intervention With Drug-eluting Stents: Results From a Patient-level Pooled Analysis of Randomized Controlled Trials (2015) (0)
TCT-420 Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention (2019) (0)
Abstract 19137: Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcutaneous Aortic Valve Replacement: Experience from the PARTNER Continued Access Registry (2014) (0)
INCIDENCE OF SEVERE DECLINE IN PLATELET COUNT IN PATIENTS TREATED BY TRANSCATHETER AORTIC VALVE REPLACEMENT AND CLINICAL OUTCOME (2013) (0)
Efficacy of gamma vascular brachytherapy for ostial versus nonostial in stent restenotic lesions (2002) (0)
The use of intracoronary ultrasound to assess post-intervention vessel wall responses (1993) (0)
TCT-449 Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent versus Cobalt-Chromium Everolimus-Eluting Stent in De Novo Native Coronary Lesions: The Final 5-Year Results of the TARGET I Randomized Controlled Trial. (2016) (0)
1101-45 Contribution of stent underexpansion to target lesion revascularization after sirolimus-eluting stenting for in-stent restenosis (2004) (0)
TCT-92 Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials (2018) (0)
Improved Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by Cardiac Computed Tomography Angiography at 45 Days Postimplant. (2022) (0)
TCT-181 Early Changes in Quality of Life after Transcatheter Aortic Valve Replacement: Results from the 3M-TAVR Trial (2018) (0)
TEMPORAL TRENDS OF INVASIVE PHYSIOLOGIC ASSESSMENT OF CORONARY ARTERY STENOSIS SEVERITY: INSIGHTS FROM A QUATERNARY-CARE CENTER IN THE UNITED STATES (2021) (0)
THE IMPACT OF SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE SAPIEN 3 REGISTRY (2019) (0)
CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective (2008) (0)
DIAGNOSTIC PERFORMANCE OF ANGIOGRAPHY-BASED FRACTIONAL FLOW RESERVE IN SUBGROUPS: REPORT FROM THE FAST-FFR STUDY (2019) (0)
The “pathology” of Renal Artery Stenosis: An Intravascular Ultrasound Study (1998) (0)
OUTCOMES OF PATIENTS WITH SMALL VESSELS UNDERGOING PCI WITH CONTEMPORARY DRUG-ELUTING STENTS: A SUB-ANALYSIS FROM THE BIONICS STUDY (2018) (0)
TRANSCATHETER AORTIC VALVE REPLACEMENT IN ONCOLOGY PATIENTS WITH AORTIC STENOSIS (2018) (0)
A symposium : transcatheter cardiovascular therapeutics (1996) (0)
An advanced antisense for local and stent based delivery for prevention of restenosis (2005) (0)
RELATIONSHIP AMONG SERIAL CORONARY ARTERIAL REMODELING, STENOSIS PROGRESSION, AND PLAQUE COMPOSITION: A VH-IVUS TISSUE CHARACTERIZATION ANALYSIS (2010) (0)
TCT-73 The Relative Effects of New Pacemakers Versus Left Bundle Branch Block on Clinical and Echocardiographic Outcomes in the PARTNER Trials (2019) (0)
FIVE-YEAR OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION BY AGE AND SEX: AN INDIVIDUAL PATIENT DATA POOLED ANALYSIS FROM 21 RANDOMIZED TRIALS (2019) (0)
Flow In Vitro (2005) (0)
EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS (2020) (0)
782-3 Rotational Atherectomy vs. Excimer Laser Angioplasty: A Multi-variable Analysis of Early and Late Procedural Outcome (1995) (0)
OUTCOMES OF THE DIFFERENT FLOW/GRADIENT PATTERNS OF AORTIC STENOSIS AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER 2A TRIAL (2017) (0)
808-2 Creatine kinase-MB elevation after coronary stenting in lesions with ruptured plaque (2004) (0)
Angiographic Follow-Up f Sirolimus-Eluting Stents for Unprotected eft Main Coronary Artery Revascularization (2016) (0)
Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI. (2022) (0)
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus (2022) (0)
GRAYSCALE INTRAVASCULAR ULTRASOUND EVIDENCE OF IN-STENT NEOATHEROSCLEROSIS 3 YEARS AFTER DRUG-ELUTING STENT IMPLANTATION (2011) (0)
TCT-166 Predictors of Target Lesion Revascularization After Implantation of Second-Generation Drug-Eluting Stents in Randomized Trials and the “Real-World”: Analysis From Two Large Datasets (2018) (0)
TCT-119 Association Among Degree of Coronary Artery Calcification, Clinical Presentation, and Adverse Clinical Outcomes After PCI: A Patient-Level Pooled Analysis of 11 Randomized Trials (2021) (0)
INTRAVASCULAR ULTRASOUND MECHANISMS OF IN-STENT RESTENOSIS IN SAPHENOUS VEIN GRAFT LESIONS (2018) (0)
IMPROVEMENTS IN PATIENT-REPORTED SLEEP AFTER TRANSCATHETER TRICUSPID VALVE REPAIR (2021) (0)
Percutaneous Endovascular Ultrasound Pulmonary Artery Denervation for the Treatment of Pulmonary Arterial Hypertension: 12-Month Results of the Trophy 1 Study (2020) (0)
TCT-7: MSCT Guided Co-registration for CTO Procedures-A Pilot Feasibility Study (2016) (0)
Carotid artery stenting 19991 (2000) (0)
TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial (2017) (0)
Abstract 2525: Two Year Outcome in Patients with Unprotected Left Main Coronary Artery Stenosis Treated with Drug-Eluting Stent Implantation: Milan and New York Experience (2008) (0)
TCT-577 Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
Abstract 15265: Trace or Mild Valvular Heart Disease With Cardiac Remodeling, Damage, and Overload in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study (2020) (0)
Abstract 69: Defining Futility in Transcatheter Aortic Valve Replacement (2013) (0)
OUTCOMES AFTER TRANSFEMORAL TAVR FROM THE NON–RANDOMIZED CONTINUED ACCESS REGISTRY OF THE PARTNER TRIAL (2013) (0)
Yyocardial Viability: A Comparative Analysis With SPECT Radionucllde Perfusion lmaglng wKornowski, (2016) (0)
Erratum: Long-term clinical outcomes with Zotarolimus-eluting versus bare-metal coronary stents (J Am Coll Cardiol Intv (2010) 3 (1240-1249)) (2011) (0)
TCT-117 Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy (2013) (0)
TCT-120 Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An individual patient data pooled analysis from 21 randomized trials (2018) (0)
omparison of Zotarolimus-Eluting nd Sirolimus-Eluting Stents in Patients ith Native Coronary Artery Disease Randomized Controlled Trial avid (2006) (0)
TCT-110 Peri-procedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs. CABG for Left Main Disease: Analysis from the EXCEL Trial (2017) (0)
PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE (2021) (0)
NINE-MONTH ANGIOGRAPHIC RESULTS FROM THE RANDOMIZED TRYTON BIFURCATION TRIAL IN DE NOVO TRUE BIFURCATION CORONARY LESIONS (2014) (0)
OUTCOMES OF CONCOMITANT TRANSCATHETER AORTIC VALVE REPLACEMENT AND PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH SEVERE AORTIC STENOSIS AND OBSTRUCTIVE CORONARY ARTERY DISEASE (2015) (0)
TCT-773 The Prognostic Significance of Changes in B-type Naturetic Peptide (BNP) after Transcatheter Aortic Valve Replacement (TAVR): THE PARTNER I EXPERIENCE (2013) (0)
TCT-282 IVUS Assessment of De Novo Ostial RCA Lesion Morphology (2021) (0)
Different mechanism of lumen enlargement in lesions with stent underexpansion after balloon angioplasty for in-stent restenosis compared to those with optimal stent expansion: an intravascular ultrasound study (2002) (0)
Sex-Related Differences in Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe AorticStenosis (0)
Abstract 4364: Variability of Distal Left Main Assessment Comparing Intravascular Ultrasound Imaging From Left Anterior Descending vs. Left Circumflex Artery (2009) (0)
1018-49 Assessing a Strategy of Stand-alone Extraction Atherectomy Followed by Staged Stent Placement in Degenerated Saphenous Vein Graft Lesions (1995) (0)
Attending to links in the safety chain for drug-eluting stents. (2006) (0)
PATHOLOGY OF EDWARDS SAPIEN TRANSCATHETER AORTIC VALVE FOLLOWING IMPLANTATION IN HUMANS (2015) (0)
oronary Artery Aneurysms After Drug-Eluting tent Implantation (2008) (0)
1001-30 Comparison of Different Vasodilators on Coronary Flow Reserve In Patients with Documented Coronary Artery Disease (1995) (0)
TCT-744 Quantitative Assessment of Balloon-Expandable Valve Position During Transcatheter Aortic Valve Replacement Using Intraoperative Transesophageal Echocardiography (2013) (0)
TCT CONNECT-128 Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-score Matched Analysis From PARTNER Trials (2020) (0)
Abstract 20549: Patient-Specific CT Image-Based Engineering Analysis of Transcatheter Aortic Valve Replacement - Implications for Aortic Root Rupture (2014) (0)
OUTCOMES OF INOPERABLE PATIENTS UNDERGOING TRANSAPICAL AND TRANSAORTIC TRANSCATHETER AORTIC VALVE REPLACEMENT: A PARTNER 2B SUBSTUDY ANALYSIS OF NESTED REGISTRIES (2014) (0)
Abstract 17178: Variability in Pacemaker Implantation in the 3M TAVR Study: Indications, Outcomes and Implications (2019) (0)
Long-Term Impact Of Iatrogenic Dissection Of A Left Main Coronary Artery During Percutaneous Coronary Intervention (2015) (0)
TCT CONNECT-89 Impact of Pre-Existent Atrial Fibrillation on Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement for Severe Aortic Stenosis: An Analysis From the PARTNER 3 Trial (2020) (0)
A COMPREHENSIVE ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DRUG-ELUTING VERSUS BARE-METAL STENTS IN ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2011) (0)
793-2 Efficacy of Locally Delivered Low Molecular Weight Heparin (Enoxaparin) on Smooth Muscle Cell Proliferation (1995) (0)
The PARTNER Trial: A New Paradigm for Treating Valvular Heart Disease (2011) (0)
1121-57 Increasing brachytherapy dose dramatically improves outcome in patients with long lesions (2004) (0)
Abstract 897: Etiology of Chronic Total Coronary Occlusions Assessed by in Vivo Intravascular Ultrasound Analysis (2008) (0)
760-2 Angiographic Outcome After “Cutting” Balloon Angioplasty (1995) (0)
LONG-TERM OUTCOMES AMONG PATIENT UNDERGOING PCI FOR OSTIAL LESIONS: AN INDIVIDUAL PATIENT-DATA POOLED ANALYSIS OF 4 RANDOMIZED CONTROLLED TRIALS (2020) (0)
Rotational Atherectomy of an Underexpanded Stent (2004) (0)
Bovine pericardium stent grafts: in vitro and animal evaluation and initial results in humans (2001) (0)
TCT-5 Long-term Preclinical In Vivo Results with a Restorative Aortic Valve (2018) (0)
TCT-695 Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis (2014) (0)
Does vessel size have an impact on recurence rates following gamma vascular brachytherapy: acute and nine-month results from SCRIPPS III registry (2002) (0)
TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program (2012) (0)
Incidence, Predictors, and Outcomes of Patients Discharged Home Versus Other Medical Facility After Transcatheter or Surgical Aortic Valve Replacement (2021) (0)
UNTREATED AORTIC STENOSISMORTALITY BY DIAGNOSIS SEVERITY: RESULTS FROM A LARGE REAL-WORLD DATABASE (2023) (0)
In saphenous vein grafts bigger is not significantly better: an intravascular ultrasound study (2002) (0)
TEMPORAL TRENDS IN THE USE OF INTRAVASCULAR IMAGING ASSESSMENT DURING CORONARY ANGIOGRAPHY AT A QUATERNARY-CARE CENTER IN THE UNITED STATES (2021) (0)
IMPLICATIONS OF WORSENING RIGHT VENTRICULAR FUNCTION FOLLOWING TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER2A (2017) (0)
Positive geometric remodelling of native denovo coronary lesions predicts clinical restenosis after stent implantation (1999) (0)
TCT-379 Independent and Combined Effect of Chronic Kidney Disease and Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
CARDIAC MATERNAL MORTALITY IN THE DEVELOPING WORLD: SCREENING PREGNANT WOMEN IN HYDERABAD, INDIA FOR STRUCTURAL HEART DISEASE (2021) (0)
TCT-27 Left ventricular function following higher-risk percutaneous coronary intervention performed with hemodynamic support (2018) (0)
Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint (2013) (0)
TCT 2010: Clinical Trials Focus on Device-Based Therapies for Cardiovascular Disease (2010) (0)
Abstract 5593: Long-term Follow-up of Patients with Unstable Angina Treated with Drug-Eluting Stents: Pooled Analysis from 14 Clinical Trials (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Martin B. Leon?

Martin B. Leon is affiliated with the following schools:

Emory University
Ohio State University
Wake Forest University
University of British Columbia
Showa University
Stanford University
Georgetown University
University of Copenhagen
Columbia University
Yonsei University
Duke University
University of Pennsylvania
McGovern Medical School

Martin B. Leon's Academic­Influence.com Rankings

Martin B. Leon's Degrees

Why Is Martin B. Leon Influential?

Martin B. Leon's Published Works

Published Works

What Schools Are Affiliated With Martin B. Leon?

Martin B. Leon's AcademicInfluence.com Rankings